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ABSTRACT

Historically, patterns of psychoactive medication use in
institutional settings for people with mental retardation
were considered excessive.

Service standards substantially

reduced levels of such medication use.

Similar research in

community settings has been limited, but comparisons between
the two settings are fraught with complicating variables.
Rapid deinstitutionalization in North Dakota provided a
unique opportunity to follow the medication use patterns of
people who stayed and those who left the institution.

Follow

up time periods were selected for statewide accreditation
(1989) and several years later through which those standards
have been consistently met (1995).

Psychoactive medication

use decreased with the onset of standards for the entire
population, and decreased for the people both within
institution and community settings by 1989.

Medication use

was highly similar between institution and community settings
at each time point, but medication use returned to near pre
standards institutional levels no matter where the individual
resided by 1995, the important exception being neuroleptics.
Neuroleptic use remained stable at the lower level
established in 1989.

XI

DEINSTITUTIONALIZATION EFFECTS ON
MEDICATION USE FOR PEOPLE WITH MENTAL RETARDATION
Paul D. Kolstoe, Ph.D.
The University of North Dakota,
Faculty Advisor:

1998

Associate Professor Joseph J. Plaud

Historically, patterns of psychoactive medication use in
institutional settings for people with mental retardation
were considered excessive.

Service standards substantially

reduced levels of such medication use.

Similar research in

community settings has been limited, but comparisons between
the two settings are fraught with complicating variables.
Rapid deinstitutionalization in North Dakota provided a
unique opportunity to follow the medication use patterns of
people who stayed and those who left the institution.

Follow

up time periods were selected for statewide accreditation
(1989) and several years later through which those standards
have been consistently met

(1995).

Psychoactive medication

use decreased with the onset of standards for the entire
population, and decreased for the people both within
institution and community settings by 1989.

Medication use

was highly similar between institution and community settings
at each time point, but medication use returned to near pre
standards institutional levels no matter where the individual
resided by 1995, the important exception being neuroleptics.
Neuroleptic use remained stable at the lower level
established in 1989.
x ii

CHAPTER I
LITERATURE REVIEW

Introductory Overview
People with mental retardation, or the more general term
developmental disabilities, were viewed as displaying
behavioral problems rather than as experiencing valid mental
illness until the 1970's and 1980's (Menolascino, Wilson,
Golden, & Ruedrich,

1986).

Medications were widely used in

the institutions to the point that substantial concerns were
expressed about their overuse (Lipman, 1970; Rivinus, 1980).
As concern developed over the types and availability of
services for people with mental retardation through the
1960's, standards for such services developed while new forms
of services -- special education, large and small group
community living, employment opportunity, and family supports
-- were introduced (Scheerenberger, 1987).

These new

services are usually more effective at promoting independence
while generally less expensive to operate, except for people
with more complicated needs (Borthwick-Duffy & Eyman, 1990) .
These new service options, increasingly funded opportunities,
and court/legislature mandated expansions produced a dramatic
decrease in institutional populations following 1969
Braddock, & Smith, 1994a & b ) .
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(Lakin,

2
Inferences about community services based upon
institutionally based research, especially in the area of
medications, are difficult to make because so many variables
differ between the two populations

(Gowdy, Zarfas & Phipps,

1987; Burd, Fisher et a l ., 1991; Burd, Williams et a l .,
1997).

The rapid deinstitutionalization which occurred in

North Dakota as a result of the ARC v. Olson (1982) court
order provides a rare opportunity to examine the change of
residential context on a group of individuals with respect to
the pattern of medication use.
Concept of Dual Diagnosis
People simultaneously evidencing conditions of mental
retardation and another form of psychopathology are often
referred to in the mental retardation literature as
experiencing dual diagnoses

(Sovner & Hurley, 1990).

This

same term is also used in other aspects of medical and
psychological research (e.g., diabetes and seizure disorder,
or chemical dependency and bipolar affective disorder), and
so may be confusing to the reader with a perspective outside
of mental retardation services; yet this sub-population is
the most noticeable of people in the community and as a group
require more extensive support services than the general
population of people with mental retardation (Borthwick-Duffy
Sc

Eyman, 19 90) .
Other commonly used terms which may be used include

psychopathology, psychiatric diagnosis
mental disorders

(disorder, condition),

(illness, health needs), emotional disorder,

maladaptive behavior, or behavioral disorder (Szymanski,
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1980).

The exact term used, and the definition of the term

as used, often varies by author.

Most authors will cite the

Diagnostic and Statistical Manual

(1980, 1987, 1994),

published by the American Psychiatric Association, as the
source of diagnoses considered as "dual".

Which diagnoses

are actually considered to be comorbid (e.g., caffeine
addiction is not likely to be included, whereas schizophrenia
is universally considered such) can vary widely between
studies and may not always be clearly explained in the
article (Reiss, 1990b).
Institutions, now often referred to as Public
Residential Facilities

(PRF's), formerly were a common

residence for many people with mental retardation, especially
those with noticeable behavior problems
1987).

(Scheerenberger,

However, over half of institutional residents in the

United States have moved to the community (Lakin, Braddock,
and Smith, 1994a & b ) .

Of the 345 PRF's operating in 1960,

116 had been closed by 1995 (34%).

The total population of

people with mental retardation in PRF's in 1967 was 194,650,
which was reduced to less than half that number by 1987 to
94,696, and these numbers were further reduced to 77,697 by
1991.

This is a reduction of 17% from 1987, and over 60%

from the 1967 population level.

The movement of the

population to the developing community services has produced
a dramatic shift in the research from "behavior problems" in
the PRF's to addressing the full range of "mental health"
problems

(Reiss, 1987) across the variety of new settings.
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Efforts at Medication Comparisons
Many attempts have been made to establish the prevalence
of dual diagnoses among people with mental retardation, but
reliance on diagnostic labels alone presents several problems
in understanding the needs for this population of people.
Borthwick-Duffy and Eyman (1990) clearly identified many of
these issues in their examination of labeling among the over
78,000 people served in the California mental retardation
service system.

They found that the presence of a second

diagnostic label for a person is affected by such issues as
questions about the accuracy of the mental retardation
diagnosis itself, isolation of a psychiatric disorder from
the effects of low intelligence, the level of cognitive
ability, the particular topography of the behaviors
displayed, and the base rates of the symptoms in each
person's setting.
Although Menolascino's group (Menolascino et a l ., 1986)
and many other leaders of the mental health movement within
mental retardation services (Kastner, Friedman, O'Brien &
Pond, 1990; Poindexter,

1989; Sovner & Hurley, 1987) urge

increased efforts to obtain accuracy in diagnoses, the
accuracy in medication use on people with mental retardation
is not made any clearer.

Bates, Smeltzer, and Arnoczky

(1986) examined the relationship between the recommended uses
of various psychotropic medications and the diagnostic labels
applied to the individuals to whom they were given.
Diagnoses were determined by evaluation teams that included
fully trained psychiatrists and the medication regimens were
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evaluated against the then most recent version of the
American Psychiatric Association's Manual for Psychiatric
Peer Review.

A range of one-third to over one-half

(39.1% to

54.6%) of the medications were rated as inappropriate for the
conditions diagnosed.
The authors clearly stated a caveat that "it is
certainly an oversimplification to evaluate individual
psychotherapeutic regimens as appropriate or inappropriate
solely on the basis of the types of drugs prescribed and the
principal diagnoses"

(p. 368).

However, they went on to note

that 14.5% of the subjects in the study who were receiving
medications had no mental disorder other than mental
retardation.

They expressed disappointment in their

findings, and concluded that "although acknowledging the
difficulty of diagnosing functional disorders in retarded
[sic] persons, we believe that most of the discrepancies
reflect errors in treatment decisions"

(p. 368).

Thus, the

pattern of medication use is not necessarily validated even
in the presence of a diagnoses.
Institutional prevalence rates of medications have been
carefully monitored in the literature since the early 1960's,
but only recently has it been studied in the community living
context (Gowdey, Zarfas, & Phipps, 1987).

Medication use in

institutions was often found to be in the 40 to 60% ranges
even into the 1980's

(Rivinus, 1980; Zaharia, 1986), although

there are several examples of substantially lower levels into
the range of 10% to 20% (Findholt & Emmett,
1989; Zaharia,

1986).

1990; Poindexter,

Concerns remain about excessive use of
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medication, as noted by Schaal and Hackenberg (1994) in their
survey of

the literature.

In their extensive review, those

authors point out that many physicians continue to prescribe
medications to manage the topography of behavior (e.g.,
aggression, withdrawal) rather than the functional issues
underlying that behavior (e.g., psychosis, depression,
attention deficits), and this may be one of the most
significant issues leading to excess use.
Rules, regulations, and standards governing medication
use have been developed in response to concerns about over
medication in P R F 's (Rinck, Guidry, & Calkins, 1989).

This

has led many physicians to be concerned about loss of
authority for medical decision-making (Kastner & Walsh, 1994)
and in some places even turned this decision making over to
the courts in review of the physicians' decisions
(Poindexter, Antanitus, Green, Cullen, & Campanella, 1994).
These rules have also been partially credited for prompting
and guiding decreases in the prevalence rates within the
large facilities

(Briggs, 1989; Poindexter,

1989; Zaharia,

1986); however, these important lessons have not been
consistently applied in community settings.

In their survey

of states' rules governing the use of psychotropic medication
in the institution versus the community, Rinck et a l . (1989)
received responses from all 50 states and the District of
Columbia as they addressed two basic issues.

They found that

responses were somewhat different between those rules applied
within institutional settings versus those applied within
community service providers.

Institutions tended to have
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more of the basic rules on implementation procedures in place
(90 to 96% versus 52 to 62%) and more standard screening for
side-effects

(61% versus 18%) than did community programs.

Rinck (1998) cited these and other studies recognizing
differences in regulation and systematic control between the
community and the more structured PRF settings.
A few researchers have examined medication prevalence in
the community systems, but the methods vary somewhat from
that used in PRF settings and the populations in each setting
differ (Luchins, Dojka, & Hanrahan, 1993) .

Individuals

residing in an institution tend to display 1)

more socially

undesirable behavior, 2) more serious or frequent aspects of
undesirable behavior, and 3) more serious medical conditions
as compared to their counterparts residing in community
settings

(Reiss, 1990a; Scheerenberger, 1983), the first two

issues being directly related to increased psychotropic
medication use

(Jacobson, 1990).

Methods used to measure who is on medications has
differed as well.

Anti-epileptic medications were included

in measures of community medication use in the few available
studies

(Gowdey, Zarfas, & Phipps, 1987; Burd, Fisher, et

a l ., 1991; Burd, Williams, et a l ., 1997).

These studies

found rates of 40%, 37%, and 38% respectively with the
antiepileptic medications, and approximately 23%, 18%, and
20% on psychotropic medications other than antiepileptics.
Buck and Sprague (1989) used the more traditional approach
without the antiepileptic medications, but their sample was
strictly people in Medicaid funded residences in the
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community in Illinois, and established a rate of 28.9%.

They

went on to compare this with a similar population of nursing
home residents

(without mental retardation) and found that

neuroleptic medication use was somewhat higher for those with
mental retardation (74% to 88% of those receiving
psychotropic medications).
Diagnosis of Psychopathology
People with developmental disabilities have received
psychotropic medications to change their behavior since they
became readily available in the early 1950's (Scheerenberger,
1987).

Initially, the medicated change in behavior was not

even conceptualized as treatment for psychopathology, as
people with mental retardation were considered primarily
behaviorally disordered or organically impaired (Reiss,
1987) .
Frank J. Menolascino, a psychiatrist who worked at the
Nebraska Psychiatric Institute treating individuals served by
the community agency ENCORE, Inc. in Omaha, has been credited
with generating much of the recognition of formal
psychopathology diagnoses for people with mental retardation.
Since 1982 the Mental Health Aspects of Developmental
Disabilities

(previously named The Habilitative Mental Health

Care Newsletter and Psychiatric Aspects of Mental Retardation
Reviews) has provided an ongoing forum for discussing the
mental health issues presented by people with mental
retardation under the editorship of psychologist Anne
DesNoyers Hurley and the late psychiatrist Robert Sovner.
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Increasing interest in the needs of people with this
form of multiple disabilities has led to the establishment of
sub-groups and independent organizations whose sole purpose
is to facilitate the development and exchange of information
on services.

NADD (previously known as the National

Association for the Dually Diagnosed) holds annual
international conferences and promotes literature focused on
various specialized topics under the combined mental
retardation and mental health banner.

Within the American

Association on Mental Retardation (AAMR), a Special Interest
Group was approved to form as an official body in its
executive board meeting in December,

1992, although

disagreement about a politically acceptable name delayed the
public announcement and full recognition until June, 1994.
At that time, the Mental Health Services Special Interest
Group (MHS-SIG) was named and attracted over 10 percent of
the AAMR membership within two years, becoming the fastest
growing and largest special interest group in the
associations history (A. Poindexter, MHS-SIG co-founder,
personal communication, June, 1996).
Much of the interest comes from the enduring lack of
information available about how to meet the needs of such
people now that there is professional acceptance of its very
existence (Sovner & Hurley, 1983).

Despite widespread

support to make use of a diagnostic system (i.e., the
Diagnostic and Statistical Manual), the currently available
system suffers from a high degree of inconsistency for people
with mental retardation (Crew, Bonaventura, & Rowe, 1994).
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Borthwick-Duffy and Eyman (1990) examined the labeling
practices used on the over 78,000 people in the California
system and found specific patterns to the application of
mental health diagnoses.

The presence or absence of such a

diagnosis is affected by such issues as the accuracy of the
mental retardation diagnosis itself, isolation of psychiatric
disorder symptoms from the effects of low intelligence,

the

level of cognitive ability, the particular topography of the
behaviors displayed, and the base rates of the symptoms in
each person's setting.
Borthwick-Duffy and Eyman noted that the accuracy of the
mental retardation diagnosis itself is more difficult around
the borderline and mild ranges of intellectual functioning.
It is often not clear to what degree the psychiatric disorder
may be imposing substantial impairment on the cognitive
abilities of the individual when attempting to accurately
assess the innate capabilities which the person may posses.
This effect is well documented in the general population
among people for whom the intellectual level was well
established before the onset of symptoms
1986; Pawlarczyk & Beckwith, 1987).

(Menolascino et a l .,

Macmann and Barnett

(1993) further examined this issue and found an overall
proportion of agreement of only .55 between psychiatrists and
psychologists in reviewing actual records of individuals with
dual diagnoses at the "cutoff" level of intellectual
performance (i.e., differential diagnosis between borderline
intellectual functioning versus mild mental retardation).
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The researchers next point, isolating a psychiatric
disorder from the effects of low intelligence,

is also one

that has been extensively discussed in the literature
(Jacobson, 1990; Pawlarcyzk & Beckwith, 1987; Sovner &
Hurley,

1986; Sturmey & Bertman,

1994).

Reiss

(1990a) argued

that there is an overshadowing effect on perception by
inexperienced mental health professionals.

These mental

health professionals assume that the low intelligence
accounts for behaviors that, in someone else, would be viewed
as symptomatic of a psychopathology different than mental
retardation.
A different aspect of the same unreliable diagnostic
patterns is also related to the level of cognitive ability as
in the previous point, resulting in an over-representation of
people with higher ability being given diagnoses as compared
to the general distribution of people with mental retardation
(Borthwick-Duffy & Eyman, 1990).

Essentially, the authors

conclude that it is the otherwise capable person who can
access more of their environment and surrounding community,
therefore the more capable people have more opportunity to
display noticeable and undesirable social behaviors.

This

increased visibility results in increased referral to mental
health services for assessment and treatment

(Borthwick-Duffy

& Eyman, 1990; Jacobson, 1990; Reiss, 1990b).
Referral to mental health evaluators is also dependent
upon the particular topography of the behaviors displayed
(e.g., aggression versus crying).

Psychotic behaviors,

example, were found by Jacobson (1990) to be reported to

for
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mental health providers significantly more often in people
with mental retardation than non psychotic maladaptive
behaviors.

He concluded that this appears to lead to an

over-diagnosis of psychotic disorders compared to those
expected for non-mentally retarded people with organic brain
syndrome, neurosis, and personality disorders

(other groups

with mental disorders), and an under diagnosis of depression
when compared to the general population rates.
The last point in Borthwick-Duffy and Eyman's (1990)
conclusion was that the base rates of symptoms in each
person's setting also impact the rate of referral to mental
health services.

Symptoms displayed in settings in which

similar symptoms are displayed by everyone may become less
noticeable because it may be more acceptable in the context
of caregiver observation.

It becomes commonplace that the

behavior occurs and the novelty wears off for the staff, who
are making judgments about whether it is a problem or not.
Another aspect of this same point is referred to as the more
"extrapunitive" behavior (e.g., aggression and destruction of
property) which is linked with increased referrals, whereas
the "intrapunitive" behaviors
sleep problem,
referred.

(e.g. sadness, regression,

low energy, inattentiveness) may be under

The distinction is that the former behavior tends

to place more demands on caregivers than does the latter.
Leading authors in the field (Sovner & Hurley,

1986;

Reiss, 1987; Kastner, Friedman, O'Brien, & Pond, 1990) have
reflected on the difficulty involved in sorting out
conflicting information about psychopathology symptoms to
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arrive at a diagnosis for people with mental retardation.
Whereas Borthwick-Duffy and Eyman (1990) addressed systemic
issues influencing diagnostics, Sovner and Hurley (1986) list
four broad presentation issues which make the process
difficult for the individual diagnostician:

1) intellectual

distortion, 2) psychosocial masking, 3) cognitive
disintegration, and 4) baseline exaggeration.
Intellectual distortion refers to diminished ability to
think abstractly and communicate intelligibly.

This can

include deficits in ability to describe one's own behavior
and feelings, therefore impairing accurate delivery of basic
information about symptoms.

In the effort to demonstrate

competence and acceptance people with intellectual deficits
encounter numerous situations where the individual may not
understand what is being asked, yet simply agree to whatever
is asked (Baroff, 1986).

Despite not understanding or being

unclear about the question posed, people with mental
retardation often overtly agree with the authority figure
even when they do not believe that they agree with what they
are saying.

In the extreme cases -- although surprisingly

frequent, according to Baroff -- this has resulted in
criminal cases where an objectively innocent individual has
been placed on death row (Perske, 1991) resulting from a
desire to please the police and judge.

Baroff, in his

research on people with mental retardation understanding
Miranda Rights, has demonstrated that questioning of
individuals with such limited powers of abstraction must be
done in a manner where the individual is able to report the
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answers in his/her own words, rather than simple parroting or
giving yes/no answers.
Psychosocial masking, another variable making
diagnostics difficult when applied to people with mental
retardation (Sovner & Hurley, 1986), refers to the likelihood
that people with mental retardation have so much narrower a
range of life experiences than their non-handicapped peers.
In describing their activity patterns, the individual may
relate very few and/or simple social behaviors and they
literally do not have the experiential resources to draw upon
to explain themselves and their symptoms.

For that matter,

without a rich background of experience, delusions of people
with mental retardation tend to resemble the fears of young
children as opposed to the generally imaginative belief
systems commonly associated with schizophrenia and mania.
Where the individual may talk of "angels" and "badmen" trying
to do something to him, the diagnostician must distinguish
between loss of reality contact versus a highly concrete and
immature -- though well grounded -- understanding of life
events.
Cognitive disintegration occurs in the general
population as a result of stress

(Sovner & Hurley,

1986).

This refers to stress-induced deterioration in intellectual
functioning and can also result in adaptive behavior
regression,

similar to pseudodementia.

This generally

reflects being overwhelmed by the events going on around the
person.

For people with mental retardation,

the arsenal of

coping skills is already limited (Hurley & Sovner, 1991) ,
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thus when a significant environmental stressor occurs the
person can quickly lose the ability to perform even simple
tasks previously mastered under more stable conditions.
Finally, the exacerbation of preexisting cognitive
deficits is referred to as baseline exaggeration (Sovner &
Hurley,

1986) .

This can be displayed as increased

distractibility, poor judgment, self-injury, or other changes
in already existing behavioral patterns which may appear to
be like, or mix with, symptoms of psychopathology.

From a

diagnostic standpoint, the change in rate or quality of a
behavior may be all that is indicative of an active
psychopathology process, rather than the onset of such
symptoms.
Kastner et a l . (1990) also described medical conditions
which can further confuse the situation.

They advocated a

thorough medical examination and encourage the physician to
carefully consider factors in addition to those raised by
Borthwick-Duffy and Eyman (1990) and Sovner and Hurley
(1986).

They point out that what appears to be maladaptive

behavior can often be the result of other issues around the
person.

Drug-induced effects can occur, such as paradoxical

hyperactivity from benzodiazepines and other tranquilizers;
dystonia, tardive dyskinesia, akathisia, and akinesia from
antipsychotic drugs; and tricyclic agents and carbamazepine
(Tegretol) have been shown to induce mania.
Even methods used in the work-up must be scrutinized,
according to Kastner et a l . (1990).

For example, wearing

medical clothing may cause a fear reaction in the individual
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and result in atypical behavior during the contact time with
the physician.

This can grossly change the impression of the

individual's presenting problem, result in treatment for
conditions unrelated to the problems encountered in daily
life, or interfere with other aspects of service.
Kastner et a l . (1990) discussed common medical problems
associated with specific syndromes that are seldom readily
obvious to many physicians.

For example, they describe

various behavioral presentations which are consistent with
depression (appetite disturbance, sleep disturbance,

loss of

energy, etc.) and note that these are also consistent with
such physical conditions as pneumonia, hyper/hypothyroidism,
dementia of the Alzheimer type, and congestive heart failure
as well as causes of mental retardation such as congenital
rubella, Down, Noonan, Turner, and fetal alcohol syndromes,
and arrested hydrocephalus.

Kastner et al. point out that

each of these are areas with which the general physician, and
often the community psychiatrist, may have little knowledge
or experience unless provided with additional resources upon
which to rely.
Even when the diagnostic category is thought to have
well-defined criteria, such as level of mental retardation,
there is significant inconsistency in actual practice.
Macmann and Barnett

(1993) summarized findings that "in

general, diagnoses of mental retardation have fared well in
DSM 'field trials' and related research, with estimates of
chance-corrected inter-rater agreement
greater than .80.",

[that are] usually

but they pointed out that this is an
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"...upperbound [sic] for estimates of inter-rater
agreement..."

(both p. 559) where all diagnostic conditions

are perfect.
McMann and Barnett (1993) examined interrater agreement
in a natural setting where the individuals also had a
secondary psychopathology diagnosis.

Psychologists and

psychiatrists independently completed evaluations on the
individuals residing at the facility in the normal course of
their duties.

Comparisons were made between the

psychiatrists' and psychologists' diagnoses of mental
retardation, and the specific level of impairment.
found that the overall chance-corrected agreement
.47 under these naturally occurring situations.

They
(kappa) was

The authors

characterize this as displaying "very little agreement"

(p.

564) between psychiatric and psychological reports contained
in client records.

Further, this illustrates that even the

most specific diagnostic criteria in the DSM still result in
poor inter-rater reliability, and therefore bring to question
validity and utility of diagnoses in this population when
making treatment decisions.
Based upon these issues the debate has been extensive
over continued use of the levels of mental retardation in the
diagnostic determination process.
Mental Retardation:
of Support

The recent Definition of

Terminology, Classification, and Systems

(Lukkason et a l ., 1992) eliminated the levels

altogether, while the Diagnostic and Statistical Manual

(4th

Edition, APA, 1994) adopted cutoff guidelines from the AAMR
publication, but did not eliminate the levels.
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Standardized assessments do not resolve the issue of
accuracy in diagnoses.

As an example, Sturmey and Bertman

(1994) validated the REISS Screen against the Psychopathology
Inventory for Mentally Retarded Adults [Psychopathology
Inventory), the Aberrant Behavior Checklist,

the assigned

diagnoses of psychopathology, actual medication use,
implementation of a behavior therapy program, and residence
on a specialized behavior modification unit.

Although

several were statistically significant (p c.Ol), the
correlations between the devices on subscales and total
scores were not a remarkable improvement from a clinical
utility perspective (e.g., r=.605)

in that barely a third of

the variance (r^=.366) is accounted for by measurement with
the instruments.
The

REISS Screen is a behavioral symptom checklist

based upon criteria in the Diagnostic and Statistical Manual
(APA, 1980, 1987, 1994), which provides a total score and
subscales that are labeled consistent to specific diagnostic
categories.

As noted above, Sturmey and Bertman (1994) also

made comparisons to clinically relevant indices of
psychopathology such as use of psychotropic medications,
presence of a psychiatric diagnosis, implementation of a
behavior therapy program, and residence on a "dual diagnosis"
unit.

The largest obtained correlations were between each

indicator variable and the total score, with only two of
these four correlations statistically significant.

Even the

statistically significant correlations were rather small
(REISS total score to psychiatric diagnosis, r =.326, p <.01;
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REISS total score to behavior therapy program, r =.426, p
<.01) suggesting poor predictive utility.
Relationship of Diagnosis and Medication
Many authors have argued that more emphasis on
diagnostic accuracy will come more precise treatment using
medications. Szymanski and Grossman (1984) assert that the
whole concept of "dual diagnosis" should be eliminated
because it encourages the development of a new area rather
than applying service systems which already exist.

They urge

use of the general system for classifying mental disorders
(i.e., DSM). but call for an intensive program for training
mental health professionals to provide a full range of
services to all persons.

In this way, the mental health

system would integrate services to people with mental
retardation rather than segregate and discriminate against
them.
Their theme is echoed by others

(Poindexter, 1989;

Sovner & Hurley, 1983), who express the opinion that with
greater education of mental health professionals about mental
retardation will come greater precision in diagnostics, and
therefore an increased accuracy in the application of
treatments such as medication.

They infer that the problem

is our systems' current inadequacy to assign a diagnosis, but
that once we have a diagnosis the appropriate treatment is
known.
This call for diagnostic accuracy as a means to achieve
greater treatment efficacy was not well-supported in findings
by Bates, Smeltzer, and Arnoczky (1986), when they examined
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the concordance between diagnoses and prescribed medications.
They examined records of individuals living in a PRF for
people with mental retardation receiving psychotropic
medications in comparison to the mental health diagnoses that
were assigned them.

Multidisciplinary teams, incorporating

fully trained psychiatrists,

identified individuals upon whom

there was unanimous agreement on the diagnosis which resulted
in selecting 62.9% of the original pool of people considered,
and ranged in level of mental retardation from mild to
profound.
The diagnoses were collapsed into the major categories
of the Diagnostic and Statistical Manual. 3rd Edition fDSMIII1 (APA, 1980) and medications were grouped by their
standard classificatory category (e.g., antipsychotics,
antidepressants, etc.) using published standards.

They rated

medication regimens for each diagnostic group to medication
class by rating them as "probably appropriate, uncertain,
probably inappropriate

or

(Bates et a l ., 1986; p. 365)" for

each individual in the study.

In addition, they evaluated

use of multiple medications by distinguishing between
copharmacy and polypharmacy as follows:

copharmacy is the

"nonredundant combinations of drugs and is not necessarily
inappropriate", whereas "polypharmacy is the simultaneous use
of two or more drugs of the same basic types and is always
inappropriate because it involves increased risk without
likelihood of increased benefit"

(p. 365).

Percentages of the total number of people were
calculated and they found that there was almost the same
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proportion of appropriate as inappropriate ratings.

Results

indicated that 15.5% of the individuals were rated as in the
Uncertain Category, 45.4% were rated as Probably Appropriate
as compared to 39.1% rated as Probably Inappropriate.

They

then used the 15.5% Uncertain Category figure to calculate
the categories potential extreme range by combining those
individuals with each category.

Thus, the authors estimate

the proportion of individuals potentially Receiving
Medications Appropriately was between 45.4% and 60.9% ,
versus 39.1% to 56.4% potentially Receiving Medications
Inappropriately.

Of those on multiple medications,

the

authors found that at least 50% were judged as Probably
Inappropriate, and that it could range up to 95.6% when
considering the Uncertain Category, despite their
differentiation for appropriateness between copharmacy and
polypharmacy.
Most striking were the conclusions expressed by the
authors

(Bates et a l ., 1986).

They explicitly understood

that their judgments of the drug regimens were lenient.

Even

regimens often regarded as inferior to others were rated in
the Appropriate Category or Uncertain Category if there were
modern references describing them as acceptable under certain
circumstances for a given diagnostic group.

Despite these

accommodations, they reflect that their findings were
"extremely disappointing"

(p. 368) and state that "we are

dismayed not only because many patients receive inappropriate
medication but also because many do not receive treatment
that can be immensely beneficial"

(p. 369).

While noting
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that successful use of the medical model requires rigorously
determined primary diagnoses, their finding illustrates the
poor relationship between the assigned diagnosis and
prescribed medication - even when the diagnoses are
unanimously agreed upon.
Rates of Medication Use
As noted previously, prevalence data on medication use
in institutions has historically been well documented at
excessive levels.

Rivinus

(1980) conducted a systematic

search of the literature, reviewing 166 studies from the
I960's through the 1980's regarding the use of medications on
people with mental retardation.

He noted a series of studies

which were completed on medication use rates in public
facilities across the United States.

These surveys reported

institutional psychotropic drug use rates to generally be
between 51% and 64%.

Lipman (1970) surveyed 109 facilities

on medication use and found that they averaged 51%.
Rivinus noted one state where one facility was large and
the other was small, each had a highly similar rate of 50% of
the population receiving psychotropic medications.

In

another case, a relatively stable average of 47% of the
people served across five facilities in eastern Canada were
receiving neuroleptic medications.

As a further example in a

state with two facilities, with an important twist, 53% of
the people received psychotropic drugs in one and 25% in the
other, despite being of comparable size and population type.
Rivinus also reported a survey of the facility in which
he was working and noted the incidence of neuroleptics use --

23
alone -- to be 57% prior to the availability of regular
psychiatric consultation.

Further, a rate of polypharmacy

was noted in 27% of the people.

After four years of regular

psychiatric consultation the neuroleptic drug use was reduced
to 23% and polypharmacy was eliminated completely.

Four

conclusions from these surveys were identified (1980, p.
198) :
1.

Psychotropic agents have come into widespread,
poorly controlled, and poorly reviewed use in
institutions for mentally retarded persons.

2.

Polypharmacy is practiced widely in institutions.

3.

The use of drugs is often the measure of the lack
of alternative approaches to unacceptable behavior
and programmatic shortcomings in most institutions
for retarded persons.

4.

Psychotropic agents can effectively be part

of the

responsible treatment and habilitative programs for
some institutionalized retarded persons.
He went on to point out that by 1980 "studies of the effect
of psychotropic agents on the functioning of
noninstitutionalized retarded fsic 1 patients are rare or
inconclusive; there is a need for such studies"

(p. 199).

Aman and Singh (1986), following up on Rivinus' article,
reviewed nine new research reports on medication use rates in
institutions.

They observed no real change in psychotropic

drug use rates among public residential facilities.

While

finding that between 40 and 50% of institutional residents
could be expected to be receiving psychotropic medication at
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any given time, they conclude that the mentally retarded are
probably among the most medicated people in society.
Standards Effect on Medication Use
Concerns about medication overuse contributed to the
development of standards of services.

In his book detailing

the changes in the latter half of the 20th century,
Scheerenberger (1987) points out that the American
Association on Mental Deficiency ([AAMD], now American
Association on Mental Retardation [AAMR]), began to establish
standards for institutions as early as 1944.

Their initial

concerns were over the optimal size of facilities, and did
little to address medical or program services.

By 1971 AAMD

joined with the American Psychological Association and
several other professional associations to establish the
Accreditation Council for Facilities for the Mentally
Retarded, more recently known as the Accreditation Council on
Services for People with Disabilities
Council].

[Accreditation

They are now known as the Council on Leadership

and Quality in Services for People with Disabilities

[The

Council].
In 1974, the standards in use by The Council were made
into the Federal Administrative Law for the Health Care
Financing Administration's

[HCFA] certification standards on

Intermediate Care Facilities for the Mentally Retarded
[ICF/MR]

(Scheerenberger,

1987).

These standards became the

criteria for states to receive federal Medicaid and Medicare
dollars in reimbursement for services of institutionalized
people with mental retardation or other developmental
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disability.

Procedural and programming requirements were

spelled out in detail.
Studies have demonstrated that the implementation of
procedural safeguards and programmatic supports mandated by
standards could reduce the rate of psychotropic medication
use substantially.

Zaharia (1986) reported how the Caswell

Center in Kingston, North Carolina, was able to reduce its
overall use of major and minor tranquilizers from 19.3 to
10.0% over a five year period.

The agency began the process

as a concerted reduction effort to meet the standards of HCFA
(sometimes also referred to as ICF/MR or Title XIX) and The
Council.
Zaharia credited a four-point approach to the medication
use in his facility with the success of the reductions.

The

first was an individualized written program for each person
regarding their drug therapy.

This involved a team effort to

develop alternatives and implement focused training by the
various disciplines.

Agency administrators increased

staffing, developed day programs, and initiated the
development of interdisciplinary teams to design
individualized services.

Second, guardian or individual

consent was obtained prior to the initiation of a
psychotropic drug.

No medication was started without the

consent of the individual, or in the case of a guardianship,
the individual

(where possible) and their guardian.

Third, the quality of the behavior therapy plans were
improved through a mandatory review by the Behavior
Management Committee.

This committee was comprised of an
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interdisciplinary mix of professionals with the
responsibility to ensure that the most effective learning
principles were employed in coordinated manner.

Review of

each plan before implementation also acted to ensure that
human rights were respected (i.e., review was completed by
the individual/guardian and their access to appeal was
guaranteed).

The fourth point Zaharia (1986) credited was a

screening program for tardive dyskinesia.

This placed a

systematic review process into the decision making regarding
the costs of using neuroleptic medications.

With this

reduction firmly in place, Zaharia commented that " . . .
control and review of drug programs were returned to medical
personnel"

(p. 12) at the end of the period under study, and

concluded with the notation that " . . .
perceptible increases in drug usage"

there have been no

(p.12) a year later.

Although Zaharia's article was in a newsletter,
Poindexter (1989) published similar data for an Intermediate
Care Facility/Mental Retardation [ICF/MR] facility in Conway,
Arkansas in one of the most respected peer-review journals
focusing on mental retardation.

The Conway Human Development

Center was ICF/MR Certified through the time of the study and
later received accreditation by The Council.

She

continuously monitored the same people over a ten year period
and recorded a decrease in psychiatric drug usage'from 32.1%
in 1978 to 12.2% in 1987, almost a two-thirds reduction.
Although not a cohort study as in Poindexter's Arkansas
research, Hancock, Weber, Kaza, and Her (1991) recorded a
similar pattern in another facility where the medication
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prevalence dropped from 30% to 12% over a ten year period,
again attributed to interdisciplinary team review processes.
Standards are sometimes criticized for infringing upon
the physician's capacity to perform effectively (Poindexter,
Antanitas et a l ., 1994) as was the case in the Caswell Center
experience described in Zaharia's quotation.

In contrast to

taking such controls away from the physician, Poindexter
(1989) pointed out physician autonomy was assured:
At no time during the 10-year period surveyed was any
attempt made by the administrators of the facility to
dictate to prescribing physicians rules or regulations
outlining drugs that could or could not be prescribed.
No legal actions were brought during this period to
force regulation of medications.

Decisions concerning

drug regimens were made individually by each physician
for his or her own patients

(p. 625).

She credited the success of the reduction to a substantially
increased involvement of the physician with the overall
planning for the individual, an increase in the amount and
frequency of information available to the physician,

improved

behavior modification techniques including increased input
from all team members, increased information to the physician
about neuroleptic drug side-effects, and greater precision in
psychodiagnostics for people with mental retardation.
Stone, Alvarez, Eliman, Horn, and White

(1989) examined

the medication rates across the eight P R F 's in California and
made comparisons with previous findings.

Medication rates

ranged from 13.7% to 63.8% in the facilities, with the higher
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rates in the two facilities that combined services for people
with mental illness with those with mental retardation.
Overall, the rates for PRF settings in California were 35.4%
and the authors concluded that rates of medication use were
dropping in comparison with earlier averages estimated around
51% by Lipman (1970).
The interdisciplinary review process has been described
earlier as receiving part of the credit for positively
affecting medication use patterns
Emmett, 1990; Glaser & Morreau,
Cotter-Mack,

1993).

(Briggs, 1989; Findholt &

1986; Lepler, Hodas, &

Whereas Findholt and Emmett reported

results consistent with Glaser and Morreau of substantial
decreases in rate of institutional medication use, Lepler et
a l . did not report similar findings in the community sample.
Glaser and Morreau (1986) compared the interdisciplinary
process in a large public residential facility to a
physician-only service program.

They selected 28 individuals

receiving neuroleptic medications and investigated the
monthly prescribing pattern of physicians over a six month
period.

This included a six-month period of monthly

interdisciplinary review meetings, attended by the physician,
clinical nurse, pharmacist, psychologist,

social worker,

mental health technician (i.e., primary caregiver), and
administrator.
The group collectively reviewed services utilizing a
four-step process.

First, the reason for the medication use

was established by the team to be either psychiatric or
behavioral control, with the specification of the target
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behavior for the behavioral control as the second step.
Third, the team reviewed the existing behavior management
program to ensure that it was current and functional and
determined the current levels of the target behaviors.

The

last step consisted of revisions of the behavior management
plan and medical regimen.
following six-month period.

This process continued for the
The differences between the two

methods of decision making resulted in elimination of the
medication for 17.9%

(5 people) of the group in the six

months, and an overall decrease across all individuals of
42.5% in daily dosage.

This was calculated through what the

authors call "oral dose equivalents"

(Glaser & Morreau, 1986,

p. 373), which was used to compare total daily doses of a
specific group of medications in a standardized manner.
Reflecting upon the mission of a formal review
committee, Findholt and Emmett (1990) explicitly noted that
their facility did not establish the Behavior and Medication
Review Committee [BMRC] to eliminate psychotropic drug use at
the institution.

Instead, it was "...formed to evaluate the

effectiveness of these medications and reduce dosages
whenever possible"

(p. 44).

Members of the committee were

the attending physician, a registered nurse, two registered
pharmacists, a psychologist, the supervisor of education, the
director of the residential living department, and the
supervisor for the resident's living area.

Although team

members were encouraged to ask questions, votes were not
taken out of respect for the physician holding the ultimate
responsibility for prescribing medications.

The committee
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reviewed each individual's treatment every 6 months through a
review of medication, diagnosis, and a graphic display of the
target behavior data.

As can be seen in Table 1, generated

from data within the article, every category of medication
decreased substantially.

Table 1.

Percentage Change Due to BMRC Review
Years

Medication Category

1979

1987

Antipsychotics

41%

12%

Antidepressants

14%

2%

Anxiolytics

13%

3%

Polypharmacy

The authors

9%

0.7%

(Findholt & Emmett, 1990) found it

interesting that the agency employed 14 different physicians
during this time period with an average length of stay of 22
months.

They concluded that the beneficial effect of the

committee was clearly demonstrated, even given the pattern of
physician changes.
In a follow-up to data collected earlier, Briggs

(1989)

examined the medication use pattern in the Walter E. Fernald
State School

(FSS) in Massachusetts, one of the nation's

oldest public institutions for people with mental
retardation.

The FSS instituted interdisciplinary review

procedures in 1980.

By 1983 the medication rate had been

brought down to approximately 20% of the population.

Briggs

examined the follow up services to these individuals to
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determine what happened to them in the intervening years
1987).

(to

The overall prevalence rate of psychiatric medication

use was reduced from approximately 44% to and maintained
around 20% for four years, and of the 130 people who were
withdrawn from the medications by 1983, 69% remained
medication free an additional four years later in 1987.
Further, of the people who had continued on medications from
1982, 91% had received dose reductions even though
discontinuation was not attempted.

Of people on medications,

99% received a behavior intervention plan detailing the
target behaviors selected for the effects of the medication.
As stated earlier, however, not all reported
interdisciplinary team review process have resulted in
decreases in the use or doses of medications.

Lepler, Hodas,

and Cotter-Mack (1993) reported on a similar process of
review instituted in a community program setting.

They cited

problems with poor communication and cooperation between the
day and residential programs, subjective reports given by
direct contact staff as the only source of psychiatric
consultation information, and lack of coordination of
treatment strategies as some of the needs for the review
process.

However, they refer to reductions in the rate of

medication use from 21% to 19%, figures representing
questionable statistical significance

(Kastner & Walsh,

1994) .
Kastner and Walsh (1994) point out that such a
difference in percentages cannot be taken to construe a true
difference, especially considering the fact that almost a
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third of the individuals about whom Lepler et al.
reported were not even seen by the review team.

(1993)
In their

response, Lepler et a l . (1994) agree with Kastner and Walsh
that there was no significant reduction as has been
consistently reported in the literature on institutional
interdisciplinary review teams.

Instead, they restate the

intent of the publication of their first article not as an
example of effective change in medication rates, but as a
model for community programs to evaluate for potential use in
their own setting.
Over medication in institutions promoted development of
several rules, regulations, and standards governing drug use
(Rinck, Guidry, & Calkins, 1989).

These rules have been

partially credited with prompting and guiding decreases in
the prevalence rates within P R F 's (Briggs, 1989; Poindexter
et a l ., 1994; Zaharia, 1986).

In their survey of states'

rules governing the use of psychotropic medication in P R F 1s
versus communities, Rinck et a l . received responses from all
50 states and the District of Columbia.

They found that

responses were somewhat different between those rules applied
to PRF settings versus those applied to community service
providers.

Institutions tended to have more of the basic

rules on implementation procedures in place

(90 to 96% versus

52 to 62%) and more standard screening for side-effects

(61%

compared to 18%) than did community programs.
The first question raised by Rinck et a l . (1989)
concerned drug evaluations.

They found that almost all of

the states 1 PRF settings were required to explicitly state
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the behaviors the medications were intended to modify
(approximately 90% of states), include methods for evaluating
the effects in the individual's treatment plan (96%), and
maintain documentation of these data in the individual's
record (90%) .

However, the same was less true for

documentation of the behavioral effects of drugs for
community service providers.

When these same issues are

applied to community services, the proportion of states
requiring that community service providers explicitly state
the behavior targeted for the medication was only 58%,
methods describing the evaluation of the medication effects
having to be included in treatment plans was 62%, and
requiring the maintenance of behavioral change data in the
individuals 1 records was present in the rules of only 52% of
the states.
The second issue examined by Rinck et a l . (1989) was the
requirement for evaluation for potential side-effects,
specifically referring to tardive dyskinesia.

Tardive

dyskinesia is a potentially permanent side effect which can
involve serious movement disorders of the arms, legs, and
torso,

facial tics, and which can even result in death (Slaw

& Kalachnik,

1985).

The monitoring for such side-effects was

required in 61% of states for PRF settings by 1987, and only
9 states (18%) for community service providers by that same
year.
The rules for the respective service settings continue
to not be consistent.

In a more recent review, Rinck (1998)

repeated the conclusion that there is a substantial effect of
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review committees demonstrated in research in PRF settings,
while finding no similar community-based studies to cite.
Medication Use in Community Settings
Only in recent years has any information been available
about medication use rates in people with mental retardation
living in the community.

In general, these rates are being

found to be similar to or even higher than the rates found in
institutions after the implementation of standards on
services

(Luchins, Dojka, & Hanrahan,

Thomas

1993; Rinck,

1998).

(1994) expresses deep concern for the arrangement

of services in the community setting, and contrasts it with
services in PRF contexts.

Noting that psychologists,

psychiatrists, general physicians, and other mental
health/retardation professionals have direct ethical
responsibility and authority over services for people in
institutions, Thomas raises the concern that inadequate
services may result from the community arrangement of an
administrator in the seat of responsibility.

Despite the

similarity between the ethical principles of the American
Psychological Association and the National Rehabilitation
Administration Association codes of ethics outlining specific
responsibilities, he contends that administrators and staff
supervisors tend to be unaware of this ethical
responsibility.

He asserts that they may accept minimally

adequate services as sufficient for people with dual
diagnoses.

He makes it clear that there is no specific such

accusation, only that the likelihood appears significantly
higher.
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Medication in the community context was first addressed
by Gowdey, Zarfas, and Phipps

(1987), but they included all

psychoactive medications in their study (i.e., antiepileptic
in addition to neuroleptics, anxiolytic, antidepressant,
etc.) to arrive at the overall medication rate of 40% for
people with mental retardation who lived in community group
homes.

This is inconsistent with the usual reporting

methods; where seizure medications were not typically counted
together with other psychoactives
1980).

(Poindexter, 1989; Rivinus,

However, Gowdy et a l . did report rates on the use of

the individual classes of medications:

14%, neuroleptics;

5%, sedative/hypnotics; 3%, antidepressants; and 1%,
antimanic.

This reflected an overall rate of approximately

23% of people on psychotropic medications other than seizure
medications.
Buck and Sprague (1989) used a slightly different
methodology to measure psychotropic medications by examining
the Medicaid billing patterns for community Medicaid funded
facilities in the communities of Illinois.

They used

pharmacy billing information to determine medications given
to individuals included in the study, although they cautioned
that it did not represent all individuals with mental
retardation living in the community.

Their findings were

specific to traditional psychoactive medications, as they did
not count any antiepileptic medications, establishing the
rate of 28.9% of the target population receiving such
medications.

Although the authors found this rate to be

comparable with nursing home patients without mental
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retardation in facilities funded in the same manner, the use
of neuroleptic medications was somewhat higher; 88% of people
with mental retardation on psychotropic medications received
neuroleptics as opposed to 74% of nursing home patients.
It is important to note that the names of these
different classes of medications have reflected, to a large
extent, the intended condition for which they are commonly
used (e.g., anti-depressant for depression, anxiolytic for
anxiety); however, the use is not restricted by such
classification (Bates, Smeltzer, & Arnoczky,

1986).

In

recent years there has been increasing use of medication with
disorders outside of the traditional class for which it is
named, such as the relatively common practice to use
antiepileptic medications for mood disorders

(Burd, Fisher,

Vesely, Williams, Kerbeshian, & Leech, 1991).
Burd, Fisher et al.

(1991) conducted their survey of all

group homes in North Dakota in 1988 and again in 1993

(Burd,

Williams et a l ., 1997) in order to comprehensively establish
the rate of medication use.

They received a 97% and 100%,

return rate, respectively, that revealed a psychotropic
medication prevalence rate of 37% in 1988 and 38% in 1993.
The North Dakota researchers

(Burd, Fisher et a l ., 1991;

Burd, Williams et a l ., 1997) used the same procedures as
Gowdey et a l . (1987) in that their methodology included
antiepileptic medications in the data collection.

As noted

earlier, however, in both of the North Dakota studies the
research teams were attempting to incorporate the fact that
antiepileptic medications were increasingly being used to
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treat non-seizure related disorders such as behavioral
problems and some psychiatric symptoms.

They also wanted to

reflect on concerns they noted in the literature about
cognitive side-effects of these medications.
eliminating anti-epileptic medications

When

(note, however, not

based on presence/absence of a seizure disorder), the
prevalence rate of medication use drops to 18% in 1988 and
20% in 1993.

These rates

(37%:18% and 38%:20%) are

relatively similar to that found by Gowdey et a l . (40%:23%).
Community rates of medication use, from what little
information is available, appear to be in the range of 18% to
40% depending upon the medications examined and the
population sampled.

In contrast, PRF levels were

historically described as between 25% and 64% depending upon
when data were collected, contemporanious standards, and
medications chosen for review.
reports

In several more recent

(Briggs, 1989; Findholt & Emmett, 1990; Poindexter,

1989; Rinck, 1998; Stone et a l ., 1989; Zaharia,

1986)

investigators report rates in the 10% to 24% range which is
somewhat lower than previous PRF rates and available
community rates.
Changes in Service Delivery in North Dakota
North Dakota established the Institution for the Feeble
Minded at Grafton, North Dakota,

for the stated purpose of

training and education in productive work such that the
individual might return to his or her community as a
productive member.

This mission was a common one for

institutions when they first opened (Scheerenberger, 1983)
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the behaviors the medications were intended to modify
(approximately 90% of states), include methods for evaluating
the effects in the individual's treatment plan (96%), and
maintain documentation of these data in the individual's
record (90%).

However, the same was less true for

documentation of the behavioral effects of drugs for
community service providers.

When these same issues are

applied to community services, the proportion of states
requiring that community service providers explicitly state
the behavior targeted for the medication was only 58%,
methods describing the evaluation of the medication effects
having to be included in treatment plans was 62%, and
requiring the maintenance of behavioral change data in the
individuals' records was present in the rules of only 52% of
the states.
The second issue examined by Rinck et a l . (1989) was the
requirement for evaluation for potential side-effects,
specifically referring to tardive dyskinesia.

Tardive

dyskinesia is a potentially permanent side effect which can
involve serious movement disorders of the arms, legs, and
torso,

facial tics, and which can even result in death (Slaw

& Kalachnik, 1985).

The monitoring for such side-effects was

required in 61% of states for PRF settings by 1987, and only
9 states

(18%) for community service providers by that same

year.
The rules for the respective service settings continue
to not be consistent.

In a more recent review, Rinck (1998)

repeated the conclusion that there is a substantial effect of
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review committees demonstrated in research in PRF settings,
while finding no similar community-based studies to cite.
Medication Use in Community Settings
Only in recent years has any information been available
about medication use rates in people with mental retardation
living in the community.

In general, these rates are being

found to be similar to or even higher than the rates found in
institutions after the implementation of standards on
services

(Luchins, Dojka, & Hanrahan,

Thomas

1993 ; Rinck,

1998) .

(1994) expresses deep concern for the arrangement

of services in the community setting, and contrasts it with
services in PRF contexts.

Noting that psychologists,

psychiatrists, general physicians, and other mental
health/retardation professionals have direct ethical
responsibility and authority over services for people in
institutions, Thomas raises the concern that inadequate
services may result from the community arrangement of an
administrator in the seat of responsibility.

Despite the

similarity between the ethical principles of the American
Psychological Association and the National Rehabilitation
Administration Association codes of ethics outlining specific
responsibilities, he contends that administrators and staff
supervisors tend to be unaware of this ethical
responsibility.

He asserts that they may accept minimally

adequate services as sufficient for people with dual
diagnoses.

He makes it clear that there is no specific such

accusation, only that the likelihood appears significantly
higher.

35
Medication in the community context was first addressed
by Gowdey, Zarfas, and Phipps

(1987), but they included all

psychoactive medications in their study (i.e., antiepileptic
in addition to neuroleptics, anxiolytic, antidepressant,
etc.) to arrive at the overall medication rate of 40% for
people with mental retardation who lived in community group
homes.

This is inconsistent with the usual reporting

methods; where seizure medications were not typically counted
together with other psychoactives
1980).

(Poindexter, 1989; Rivinus,

However, Gowdy et a l . did report rates on the use of

the individual classes of medications:

14%, neuroleptics;

5%, sedative/hypnotics; 3%, antidepressants; and 1%,
antimanic.

This reflected an overall rate of approximately

23% of people on psychotropic medications other than seizure
medications.
Buck and Sprague

(1989) used a slightly different

methodology to measure psychotropic medications by examining
the Medicaid billing patterns for community Medicaid funded
facilities in the communities of Illinois.

They used

pharmacy billing information to determine medications given
to individuals included in the study, although they cautioned
that it did not represent all individuals with mental
retardation living in the community.

Their findings were

specific to traditional psychoactive medications, as they did
not count any antiepileptic medications, establishing the
rate of 28.9% of the target population receiving such
medications.

Although the authors found this rate to be

comparable with nursing home patients without mental
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retardation in facilities funded in the same manner, the use
of neuroleptic medications was somewhat higher; 88% of people
with mental retardation on psychotropic medications received
neuroleptics as opposed to 74% of nursing home patients.
It is important to note that the names of these
different classes of medications have reflected, to a large
extent, the intended condition for which they are commonly
used (e.g., anti-depressant for depression, anxiolytic for
anxiety); however, the use is not restricted by such
classification (Bates, Smeltzer, & Arnoczky,

1986).

In

recent years there has been increasing use of medication with
disorders outside of the traditional class for which it is
named, such as the relatively common practice to use
antiepileptic medications for mood disorders

(Burd, Fisher,

Vesely, Williams, Kerbeshian, & Leech, 1991).
Burd, Fisher et a l . (1991) conducted their survey of all
group homes in North Dakota in 1988 and again in 1993

(Burd,

Williams et a l ., 1997) in order to comprehensively establish
the rate of medication use.

They received a 97% and 100%,

return rate, respectively, that revealed a psychotropic
medication prevalence rate of 37% in 1988 and 38% in 1993.
The North Dakota researchers

(Burd, Fisher et a l ., 1991;

Burd, Williams et a l ., 1997) used the same procedures as
Gowdey et a l . (1987) in that their methodology included
antiepileptic medications in the data collection.
earlier, however,

As noted

in both of the North Dakota studies the

research teams were attempting to incorporate the fact that
antiepileptic medications were increasingly being used to
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treat non-seizure related disorders such as behavioral
problems and some psychiatric symptoms.

They also wanted to

reflect on concerns they noted in the literature about
cognitive side-effects of these medications.
eliminating anti-epileptic medications

When

(note, however, not

based on presence/absence of a seizure disorder), the
prevalence rate of medication use drops to 18% in 1988 and
20% in 1993.

These rates

(37%:18% and 38%:20%) are

relatively similar to that found by Gowdey et a l . (40%:23%).
Community rates of medication use, from what little
information is available, appear to be in the range of 18% to
40% depending upon the medications examined and the
population sampled.

In contrast, PRF levels were

historically described as between 25% and 64% depending upon
when data were collected, contemporanious standards, and
medications chosen for review.
reports

In several more recent

(Briggs, 1989; Findholt & Emmett, 1990; Poindexter,

1989; Rinck, 1998; Stone et a l ., 1989; Zaharia,

1986)

investigators report rates in the 10% to 24% range which is
somewhat lower than previous PRF rates and available
community rates.
Changes in Service Delivery in North Dakota
North Dakota established the Institution for the Feeble
Minded at Grafton, North Dakota,

for the stated purpose of

training and education in productive work such that the
individual might return to his or her community as a
productive member.

This mission was a common one for

institutions when they first opened (Scheerenberger, 1983)
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and was reflected in much of the self-sufficiency of the
facilities.

A 1907 letter from superintendent refused

admission for an individual whose handicap was so severe that
"he would not receive benefit" the training.

The

capabilities of many people were developed to the point that
a superintendent in the 1930's established a brass band which
was admired by many of the people in the communities around
Grafton (personal communication/photograph in class "History
of the Developmental Center" by Ken Weisen, Director of
Personnel, North Dakota Developmental Center, October, 1996).
The mission of educating the residents was reflected in
the name change in 1933 to the Grafton State School.
Throughout the years, individuals were placed out of the
facility into homes,

factories, cafes/restaurants and other

settings were the supervising family was expected to provide
a job, supervision, a residence and personal time in exchange
for their labor.

The term "Job Training/Placement" was used

in records as early as 1907 and continues to be the official
term used by the records staff to denote the individual
moving to a work/residential setting in the community.
The population of the Grafton State School continued to
grow through the century.

The additional site of the San

Haven Tuberculosis Sanitorium came under the authority of the
Grafton State School Superintendent during the 1960's and
appears to have become almost exclusively populated by people
with mental retardation.

As is true of the institutionalized

population of the United States

(Lakin, Braddock & Smith,

1994b), the institutionalized population at Grafton/San Haven
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began to decrease after 1969

(see Figure 1).

This is likely

due to the emerging availability of special education
programs and some community opportunities following President
Kennedy's administration (Scheerenberger,

1987).

Events affecting the delivery of services and the living
conditions for people with mental retardation in North Dakota
began a radical change in the early 1980's.
Association for Retarded Citizens

The North Dakota

(ARC) and six citizens with

mental retardation filed suit in the Federal District Court
of North Dakota seeking declaratory and injunctive relief
under the First, Fourth, Fifth, Eighth, Ninth, and Fourteenth
Amendments to the United States Constitution, as well as
several federal Acts and North Dakota state laws (ARC v .
Olson. 1982) .
When the ARC filed its complaint in September,

1980, the

district court granted class certification consisting of the
ARC and all persons who, as of September 26, 1980, and at any
time thereafter, have been or may become residents of the
state's institutions for the mentally retarded.

Although the

complaint was filed and certified, the court granted a stay
to permit the North Dakota legislature to resolve the issues
raised during its sessions, which began in January, 1981.
Immediately after the legislature concluded business in May,
1981 the court lifted the stay and interceded in the state's
operation of the services by appointing a court monitor to
report to the court on activities of the state.

Plaintiffs

had not been satisfied with the legislature's attempt to
rectify the conditions at the facility and in the state.

Figure i. N.D. Developmental Center
San Haven and total staff levels

(1904-present) population with available
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Trial commenced in January, 1982 and the order was
handed down the following May which required, among other
issues, that the state permanently comply with all Title XIX
regulations of the Social Security Act (Title XIX - Health
Care Finance Administration [HCFA]) by July, 1985 and to
comply with all ACMR/DD (The Council) standards by July, 1987
at all facilities where any class member resided (ARC v .
Olson, 1982).

The standards which were required to be

implemented include management systems for medication use.
The court further required the state to develop community
based residential services sufficient to reduce the combined
institutional population to 450 by July, 1987 and to 250 by
July, 1989.

The state has since met these requirements and

the court's involvement ended in May, 1995.
These changes have resulted in the movement of nearly
700 people from the institution to the community, the closure
of the San Haven facility, and all agencies -- as required by
the court -- have met Title XIX and The Council standards
since the Developmental Center achieved that status in April,
1989

(two years later than was ordered by the court).
Under these standards, all psychotropic medications used

to modify behaviors, other than seizure-related conditions,
must have plans for their use outlined in a plan written by
the team and reviewed by behavior intervention review and
human rights committees

(Gardner, 1990).

Thus, all

individuals with mental retardation in North Dakota receiving
psychotropic medications were receiving planning, review, and
oversight that have been reported as reducing medication use
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levels in institutions

(Kastner & Walsh, 1994; Rinck, 1998).

As of the time of this dissertation (1998) all services in
North Dakota had maintained certification and/or
accreditation as had been ordered.
Statement of the Problem
It is difficult to make comparisons between medication
rates for institution and community populations of people
with mental retardation.

Those who remain living in the

institution tend to display more severe psychopathology than
the individuals living in the community (Luchin et a l ., 1993)
so such comparisons have become less meaningful as people
have moved to the community (i.e., deinstitutionalization)
and others in the community have been referred to mental
health services

(Jacobson, 1990).

The people who are

admitted to such facilities, or remain institutionalized, are
more likely to display severe maladaptive behavior, often
being assigned a mental health diagnosis, thus increasing the
base rate of problems likely to generate treatment with
medications

(Borthwick-Duffy & Eyman, 1990).

Medication use rates on individuals for whom both
institutional and community living have been a part of their
lives are examined.

By following such individuals over time,

conclusions can be derived about effects of the different
settings and the impact of standards.

This is accomplished

by examining the individuals who were living in the
institution as it was, and are now living in the institution
and community under current standards.

As outlined from the

literature, medication use has been more closely monitored in
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the PRF setting and community dual diagnosis services have
been characterized as more loosely developed and organized.
Three basic issues are examined.
First, it is clear from previous studies conducted
within institutions that the initiation of standards and
development of a systematic review processes has resulted in
a decrease in medication use for those continuing to reside
in that setting (Rinck, 1998).

Thus, the assertion that

medication rates have been reduced among the individuals
remaining in the institutional setting given the introduction
of regulations will be examined.
Second, there is very little research available on
medication use for people that have moved from institutions
to communities; however, use of the planning and review
systems appears to have a significant impact at reducing the
rate of medication use in the institution.

Where rates have

been measured in the community, they appear to be in a
similar range as rates historically measured in institutional
settings.

In fact, there are more recent reports where

institutional rates have been found to be lower than those
found in the community (Rinck, 1998).

From this difference

in service settings it is hypothesized that medication rates
for the group of individuals that moved into the community
from the institution are higher than those who did not move.
Third, it is the widely held that people were admitted
to the institutions due to problems they encountered while
living in the community for which there were inadequate
supports (Scheerenberger, 1983).

The supports that have been
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created have allowed many of these individuals to return to
the community, but there are now greater opportunities to be
recognized for deviant behavior and therefore to be referred
to mental health services

(Reiss, 1990a).

To examine the

accuracy of this assertion it would be appropriate to test
the statement that medication rates on individuals currently
in the community are greater than their proportion under pre
standards institutional living.

For this to be accurate, a

greater proportion of people would be on psychotropic
medications now that they are living in the community than
when the same group was living in the institution.

CHAPTER II
METHOD
Subj ects
The records of 1,077 individuals recorded as living at
the Grafton State School (now known as the North Dakota
Developmental Center) and the San Haven facility on January
1, 1980 were followed on two later dates, January 1, 1989 and
January 1, 1995.

Of the 1,012

(94%) people with records

found, 539 (53.3%) are male and 473 (46.7%) are female, with
the age range from 1 year, 4.5 months to 90 years,
in 1980.

10 months

Although the July 1, 1980 census for the Grafton

facility showed 829 people on the records, this project
identified 867 people estimated to be at the Grafton facility
by the data collected around the January 1, 1980 date.

The

excess is related to the movement of people between the two
facilities with records that are unclear as to the person's
exact location on the target date.

Of the 867 identified at

Grafton, the gender proportions were the same as the total
population,

52.9%

(459) were males and 47.1%

(408) were

females.
A distinction between the total population (both Grafton
and San Haven residents) and the Grafton facility residents
is made in several instances.

Historical administrative

statistics are available for the Grafton facility alone for
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which comparisons of reliability and validity are based.

At

the outset of the study, only Grafton individuals were going
to be considered as the records were known to be in
relatively good condition.

As the San Haven facility was

closed, the records received at the Grafton facility arrived
disorganized with several records of people appearing to have
been lost.

Given this pattern, the people at San Haven were

not going to be included out of concern for a lack of
accessibility.

As data collection began, it was necessary

that records from both facilities be examined as people were
moved between them on a regular basis.

As well, those

records from the San Haven facility that could be found had
appropriate data in most cases and findings about all of the
people "institutionalized" in North Dakota would be more
complete if they were included.
The age of individuals averaged 37.09
at the 1980 study date and averaged 12.82

(SD = 17.11) years
(SD = 10.93) years

old when they were admitted to the institutional system.
Study Variables
A number of variables were defined for data collection
about this population of institutionalized people.

As

mentioned earlier, the definition of Institutionalized was
required to be revised almost immediately upon initiation of
data collection due to confusion in the records.

However,

the final result is a more complete assessment of the
experiences of institutionalization during years of such
phenomenal changes in public policy.
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The dates of the study (Study Dates of January 1 of
1980, 1989, 1995) represent three stages.

The 1980 time

period represents those experiences prior to systematic use
of externally evaluated professional standards and prior to
the court-ordered deinstitutionalization.

The second point,

1989, represents the point at which the newly developing
system has met all standards required by the court for the
first time and a substantial number of people have moved from
the institution to live in services covered by the same
standards in the community.

Change is seldom permanent, but

without a measure of the stability of change following such
sweeping public policy shifts, outcomes fail to be
meaningfully evaluated for endurance.

The conclusion of the

lawsuit (ARC vs. Olson. 1982) in 1995 reflects a time at
which the public policy change agents have concluded the
system is adequately stable such that further mandates were
not required.
Each time variable was also selected because of
proximity to other time variables available for comparison.
In association with efforts of the lawsuit, medication use
patterns in the North Dakota community-based developmental
disabilities system first occurred in 1988 (Burd, Fisher et
a l . 1991) and was repeated in 1993
1997).

(Burd, Williams et a l .

The dates, although not precisely overlapping,

provide a comparison within the same geographic region at
similar time points and an overlapping of people.
The total cohort of people during this period of
institutional and community living conditions permit
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comparisons between medication use rates in both sites, while
following the same cohort of individuals through time and
settings/events.
Although the total institutionalized population is
examined, each individual's residence as indicated in the
record is maintained in the database so that in some
instances the Grafton group can be separated from the San
Haven facility.

The separation enables an evaluation of

differences, noting similarities, and relating reliability/
validity measures taken just at Grafton to the appropriate
sub-populations.
Diagnoses are coded by the major categories of the
Diagnostic and Statistical Manual. 4th Edition (APA, 1994)
and examined at each point in time.

The broad diagnostic

categories were used rather than specific diagnoses both
because of the changing diagnostic concepts over time, but
also for categorization at a level of data aggregation that
permitted comparisons to be made.
by other authors

This method has been used

(Bates, Smeltzer & Arnoczky, 1986; Burd,

Fisher et al, 1991; Burd, Williams et a l ., 1997).
Medication categories based upon classifications in the
Physician's Desk Reference (Medical Economics Company, 1997)
were also selected based upon similar procedures by other
authors and for the same basic purposes of data management as
diagnostics

(Bates, Smeltzer & Arnoczky,

1986; Burd, Fisher

et al, 1991; Burd, Williams et a l ., 1997).

Medication dose

comparisons are difficult to be made directly with one
another because there are few commonalities between them.

Only the Neuroleptics

(e.g., haloperidol, thioridazine, etc.)

have a relative potency table which permits a measure of
comparison (Maxmen, 1991).

Data on doses were collected on

all individuals where available.

No data recorders were

asked to codify the diagnoses, medications, or doses as each
recorder simply recorded verbatim the actual diagnoses,
medications and doses by the names, codes, and measurements
available in the record.

The Psychoactive variable consists

of both medications used for seizure management and
medications used for psychiatric/behavioral change in the
individual, with the addition of the Beta blocker Inderal,
which was found to have frequent psychiatric/behavioral
change uses.

Psychiatric use medications are those

identified for use in the records for the change of
psychopathological symptoms or behavior, whether a specific
diagnosis is provided or not.

The Seizure medication

variable consists of medications used for epilepsy as
indicated in the record.

Finally, the Neuroleptic variable

consists of those antipsychotic medications for which there
is a potency equivalence formula enabling the comparison of
doses

(Maxmen, 1991).
Level of mental retardation was taken from psychological

evaluations nearest to 1980.

Presence of a seizure disorder

was determined if there was a medical diagnosis of the
seizure disorder in each of the years of the study.

Date of

birth was taken from birth certificates where possible, or
from the most reliable document available in the record based
upon the professional experience of the data collector.

In a
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few cases, no actual birth date is available because birth
records in North Dakota -- and some other states -- in the
late 1800's and early 1900's were not highly systematized.
In those cases, the birth date accepted as the best
approximation by the facility was used.

Date of admission is

the date admitted to the institution without placement until
after 1980.

Placement date was the last date of placement

prior to either Study Date.

Of the 115 people remaining in

the institution in 1995, only two (1.7%) had been on
placement on the Study Date in 1989.

Discharge dates were

also collected as a means of assisting in tracking people.
The Placement Date is when the individual moves out of the
facility to reside elsewhere, whereas the Discharge Date is
that date at which the individual is removed from the Roster
of the Developmental Center.

The exact meaning and purpose

of the Roster goes back to ease of returning a person to the
institution, a distinction which became virtually meaningless
over time.

However, mail was sent to people on the Roster

which sometimes provided evidence of residence, survival, and
death.
Date of death reflects the date recorded as the person
having died; however, sources of information on death did not
always provide exact dates.

Sources of death included death

certificates on file in the archive,

letters announcing the

individual's death in the archive, a search by the North
Dakota Department of Vital Statistics, human service center
file entries, and the Social Service Death Index (SSDI).

The

SSDI is an electronic website (www.ssdi.archive.com) at which
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a database of death information taken from the Social
Security Administration death files can be searched by social
security number, name, residence, or even dates of birth or
death.

In several cases the date of death is limited to the

month and year.

In those cases, the first of the month was

arbitrarily selected to represent the specific date of death.
Etiology of mental retardation was taken from records
indicating a professional opinion about the cause of the
mental retardation.

It should be noted, however, that the

basis for such professional opinion varied and were often
reflective of theories active at different points in history.
A common example is an etiology of cultural-familial cause
which could range from genetically influenced (e.g., a "slow"
family as one social history noted) to situational

(e.g. one

individual that only spoke Norwegian was admitted in the
1930's for having attempted to harvest his neighbor's land
and the sheriff could not understand him).

Most etiological

classifications of Down Syndrome did have support of
genotyping, as did several other genetic disorders.
The diagnosis of Autism or Pervasive Developmental
Disorder was not included in the Diagnosis category because
of the etiological implications and as a means of keeping it
separated from the already-broad category of Disorders
Usually First Diagnosed in Infancy, Childhood, or
Adolescence.

These diagnoses can range from learning

disabilities to conduct disorder, movement disorders, and
genetic abnormalities

(e.g., Rett Syndrome).
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Materials
The investigator, research assistant, and Human Service
Center Developmental Disabilities Casemanagers

(DDCMs) used

the same data collection forms to search the current and
archived records of each individual.

There was a section of

the form for each time period on which the individual's code
number was identified on each page.

The individual's name,

for use by those authorized to review the records during the
collection phase, was identified with the code on a label
pasted to the forms.

The label included the individual name,

Social Security Number, date of birth, date of placement,
region placed to, agency placed to, and gender.
The archived Developmental Center data was collected
first in order to:
records
2)

1) base identification on original

(including birth certificate,

Social Security card);

minimize the volume of data for the DDCMs in the

community to complete; and 3) clarify the individual's
qualifications for participation to minimize excess effort.
The records clerk maintains a master list of identification
codes to permit follow-up studies by qualified investigators.
The data collection form for each follow up survey date
(i.e., 1989, 1995) was color coded to promote accuracy, with
only the 1995 form prepared for those placed after January 1,
1989.

For those forms disseminated to Developmental

Disabilities Program Administrators
instruction sheets.

(DDPA) there were

They were for the DDPA's to help answer

questions DDCMs might have, in addition to the individual
instruction sheet for the DDCM to use.
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The community based data collector (DDCM) could indicate
information about the individual's death whether prior to or
after the study date, if it applied.

Type of residence and

vocational activity were circled from among the choices,
which were supplied by the Division of Disability Services
(the central state agency which determines services
available).
Data spaces are provided for up to eight diagnoses of
medical conditions and/or psychopathology as identified in
sources of information with which the DDCM is highly familiar
as a central part of the job description.

These sources were

the same as those examined in the institution's archive for
the 1980 data collection and could be from a variety of
sources including the individual's program planning document,
psychological evaluation, physician record, or psychiatric
consultation note.

Similarly, nine spaces are provided to

list all medications prescribed as of that date and the dose
per day.

For each, the diagnoses and the medications, a

"Date of Data Source" by month and year of the document is
collected in order to permit an estimate of how consistent
the time point of information was available across
individuals.

For example, one individual may have seen a

physician on the exact date with diagnoses and medications
prescribed noted on that day (a highly unlikely event, given
the day was a national holiday in each case), yet another
individual may have last been seen in the DDCMs records in
the previous July and another not have had a psychological
evaluation or psychiatric visit for four years

(because he or

she did not display a need for those services).

In this last

case, the most recent review of the diagnosis may be up to
several YEARS prior to the study date.

Instructions were to

identify two points of information around the Study Date, and
use that to interpolate the specific medication dose.
Additional data, although not directly involved in the
analysis of the hypotheses, is collected to provide further
characteristics of the population.

Such variables include:

type of residence, closest adaptive behavior measure,
intellectual and/or mental age measure, original date of
institutionalization,

length of stay, years in the community,

and county/region of admission.
Procedure
The procedure of the study is straightforward as an
archival project.

The subjects at the Center on January 1,

1980 were identified through a systematic review of
admission, discharge, and transfer records.

Each

individual's file was examined in the archive of the Center
for the relevant variables as of 1980.

Forms for individuals

found and thought to be surviving to 1989 and 1995 were
created and disseminated to the regional human service
centers.

People moving across regions or unfamiliar to the

region were referred back to the investigator.

For those

people remaining at the Center, each person's archive file
was further examined for the 1989 and 1995 data points.
Although some DDCM's completed the community data forms,
most of them were completed by the principal investigator
traveling to each human service center, except for one, and

examining the records on each person that were available.
Closed records older than three years were often not
available and are considered missing data points for that
Study Date.
Individuals were tracked through the Central Records
Department of the Developmental Center, the computerized
files of the Division on Developmental Disabilities of the
Department of Human Services, and by case managers in each of
the eight Human Service Centers throughout North Dakota.
Consent for involvement in the study was not relevant as this
is a review of existing records of treatment, does not
involve any manipulation, and confidentiality of individuals
is maintained.

Although provisions were being made to

contact those people leaving the state, the small numbers of
people (13 people or 1.2% of the original census) made for a
negligible impact which, when compounded with years of lost
contact, made this impractical and meaningless.
Each individual is identified by name and social
security number within the North Dakota Department of Human
Services

(DHS) and were additionally assigned individual

subject codes for data handling.

The codes and names for

each person, both those currently living in the Developmental
Center and those living in the community, will continue to be
maintained by the Records Clerk of the Developmental Center
for cross-referencing purposes and further research on this
population.

Such responsibilities are consistent with the

job position relative to the maintenance of information on
people with developmental disabilities in North Dakota.
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Approval for the research was obtained from the
Institutional Review Board of the University of North Dakota,
the Research Services Committee, Human Rights Committee, and
Superintendent of the North Dakota Developmental Center, and
Director of Management Services (Chief Financial Officer) in
the Department of Human Services prior to the formal data
collection.

In preparation for proposing the project, data

relevant to the operation of the Developmental Center and
consistent with employment responsibilities of the principal
investigator was examined to estimate the logistical
viability of the project.

Records based in the regional

mental health centers had not been systematically examined
prior to the study, except through individual cases referred
to the Developmental Center, prior to the project beginning.
A single research assistant was involved with the
investigator in extracting the data from the archive records
of the Center to complete the forms.

Of the possible maximum

of 25 items on each archival form that could be completed,
ten records were examined by both workers with three coding
items different

(1.2%) between them, none of which in this

instance would impact the final coding of the data (i.e., a
mistaken Social Security digit, misspelled county name, and a
placement and discharge date interchanged).
Both the investigator and DDCMs collected data in the
community settings.

Developmental Disabilities Casemanagers'

(DDCM) job responsibilities include the facilitation of all
services for people identified as being entitled to services,
which specifically includes all individuals residing at the
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San Haven and Grafton facilities as of January 1, 1980.

They

are trained in record keeping and in obtaining all services
for the individual including residential, vocational,
medical, and other need areas.

Many individuals are likely

served by private residential and vocational services, whose
records on the individual are considered open for review by
casemanagers and from whom assistance in obtaining
information is regularly obtained by the DDCM.
The current location of each individual, or their
location at the time of death, was ascertained through
Developmental Center records, Division of Developmental
Disabilities computerized records, and the assistance of each
of the eight regional human service centers' DDPA.

A

preliminary list was sent to each DDPA for them to check
against the records in their region prior to disseminating
forms.

With agency support from a few of the D D P A 's ,

casemanagers were provided information about the study and
the nature of the information to collect.

They were provided

forms for the individuals on their caseload as well as those
on their caseload upon the individual's death.

In one

region, all forms (40) were completed by the DDCMs, in
another region about one-third of the forms were done by
DDCMs

(40), and in a third region there were a few completed

by the DDCMs

(25).

In all other cases, the principal

investigator completed the community forms from records at
each human service center.
Data was accumulated from files of the Developmental
Center from documents most closely related to the target
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information; for example, diagnoses were taken primarily from
psychological evaluations as they were a consistent source of
diagnosis listing.

Medical diagnoses were reviewed in those

evaluations and in medical evaluation forms which began in
1981.

Full time physicians were consistently employed at the

Developmental Center since the facility had opened, and all
prescriptions were being recorded in the Medical Running
Record document at that time.

The psychological evaluations

also provided level of mental retardation,

intellectual

testing, adaptive testing, and etiological information.
Birth certificates and social security cards were maintained
on everyone that was at the facility after approximately
1981, unless their record was damaged.
Later information (medications and diagnoses)

for people

residing in the Center were available from the computer
database as a result of real-time data entry.

All Center

data was considered to be accurate for the study dates
(month/year zero) because it was taken directly from the
specifically active database coded to be relevant to the
person at the time.

The same way with medications, as the

prescription for that date and would show canceled or changed
if there had been any changes.
For the community data collection sheets, the diagnoses
were taken from any psychological evaluation, team planning
document, medical evaluation, or psychiatric chart note which
was the closest to yet still preceded the Study Date of data
collection.

For example, if there were a psychological

evaluation dated 10/15/1987 and another 3/12/1993, the
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date/month would be 10/87 for the 1989 study date and 3/93
for the 1995 study date.
In coding, this would be considered 12/88 minus 10/87
(scored -14 months) and 12/94 minus 3/93

(scored -21 months).

In each calculation the sign was preserved with items found
in documents after the study date considered positive months.
In each situation, however, there were occasions where the
only data available had to be found on the "wrong" side of
January 1 of the study target date as the best estimate of
their status at the time.
Information on some individuals did not survive in the
service system.

This may have occurred for a variety of

reasons, such as loss of records at the San Haven facility
(estimated at N=52, 4.8% of census), misfiling of materials,
moving out of the state (N=13, 1.2% of census), discharge
from the developmental disabilities services, or expiration
of the storage period (minimum of three years) after any of
these events or death, the latter of which are accounted for
in the results as missing data.

The exact location of 69

people (6.4% of 1,077 Census) whose 1980 records were found
is yet beyond the resources of this investigator to find.
The number of "lost" people was anticipated to be limited due
to the state's general practice to maintain periodic contact
with all individuals receiving services.
January 1, 1989, reflects the earliest moment in which
all individuals with developmental disabilities received
services certified under the Health Care Financing
Administration (HCFA) standards and a point at which all

services were at a level which the The Council grants
Accreditation status for compliance to their standards.
January 1, 1995, represents a point in which all services
have met or exceeded the HCFA and Council standards for more
than five years, thus demonstrating a consistent pattern of
meeting those standards with a maturing service delivery
system.

Furthermore, the data was anticipated to be

collected in 1996-97 in which records would have sustained
the 1995 data more effectively than when it was collected in
1998 .
The data was unable to be collected due to unforeseen
and insurmountable obstacles in 1996-97.

At the initiation

of the data collection in 1998, the 1995 date was maintained
because:

1) a substantial proportion of data was estimated

to still be collectible for meaningful analysis

(as had been

estimated of the 1989 data in the original design);

2)

concern over the likely mounting mortality loss of the
population;

3) comparative power with the Burd, Williams et

a l . (1997) 1993 North Dakota data; and 4) to permit future
follow-up studies a larger time span in which to examine
system and population change against data collected at the
point the lawsuit was closed.

Data on deaths and residence

was collected for the time period after 1995 for future
researcher use.
Support and cooperation for the research was obtained
from the Chief Financial Officer of the Department of Human
Services, who is the legal authority to approve research
conducted in the records of state agencies.

The Director of
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Disability Services, each Regional DDPA, and initially the
Director of Human Services

(the Director at the beginning of

the project resigned in 1995) were included in meetings in
advance to foster their support.

In addition, an

informational telephone number and e-mail address was offered
to regional case managers to use to answer questions, assist
in solving problems, or coordinate finding information which
may have proven to be elusive.

No such requests for further

information was received and interviews of those completing
the forms revealed they were clear and understandable.

No

forms completed by the DDCMs required follow up for more
information or clarification, even of their handwriting.
Reliability/validity is best determined by comparison
with administrative reports from 1980 and 1989 for the
institutional context.

This was determined to provide a more

efficient, empirically valid, and reliable estimate of
accuracy than individual form calculation.
Once data was collected and recorded, the data is boxed
for storage.

If additional information is necessary to be

further examined the Record Clerk of the Developmental Center
will match the forms to support confidentiality.
The study results will be shared with the Department of
Human Services, which includes the Developmental Center, the
Developmental Disabilities Division, and the regional centers
in exchange for the support, assistance, and permissions.

In

addition, a gift certificate drawing provided incentive for
DDCM assistance.

Since research funds were not available to

provide a gift certificate for each participating DDCM,
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subject numbers are randomly selected until eight of the
contributing DDCMs are identified to receive the gift.

All

assisting DDCMs are receiving a note of thanks.
Data manipulation has been continuously updated with
subject information in a database file.

The data was

converted to SPSS for Windows statistical software package
(Version 7.5.1, 1996) for analysis and all entry and coding
was done by the principal investigator.
Coding of each set of variables was based upon existing
categories.

Each individual was coded to home region (region

of the admission county) and each study date location by
region of residence.

Gender, dates and Grafton/San Haven

facility residence are self-explanatory.

CHAPTER III
RESULTS
Data Collection Time Characteristics
In contrast to one another, diagnostic information was
found to be more accurate from documents before the study
date, but medication dose information was generally found in
documents after the study dates to be most accurate (see
Table 2) .

A physician's appointment in 2/95 that indicated

the dose of depakote would increase from 600 to 700
milligrams was generally a better source of information than
one from the previous July, as the records were not clear
enough about whether further appointments occurred after
July.

Thus, the months of Diagnostic Information reflect a

negative average near zero and the month of medications and
their dose information reflect a positive average near zero.

Table 2. Months of document before/after target Study Date
for Diagnostic Information and Medication Information.

N

Mean
Months

Diagnostic 1989

710

- .85

9.95

- .575

Diagnostic 1995

711

-2.59

13.68

-1.791

Medication 1989

661

.58

7.45

.562

Medication 1995

663

1.30

7.12

-.175

Data Category
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St d .
Deviation

Skewness
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The diagnostic information has a much broader
distribution skewed heavily towards earlier months

(Table 2),

which reflects the large number of individuals whose only
diagnosis of psychopathology is mental retardation, testing
for which is not repeated frequently once clearly
established.

People without significant problems often had

an evaluation even as early as 1988 and may never have had
another since (thus, the same evaluation serving both 1989
and 1995 study dates).

The distribution of medication

information tended to reflect specific physician appointments
held during that year, even an annual physical for those on
no medications.
Demographics of the Population
Descriptive characteristics of people institutionalized
in North Dakota as of January 1, 1980, are developed for the
variables of the study and used in the comparisons.

An alpha

level of .01 was used in all statistical tests.
Because the two facilities' populations were originally
intended to be separated, unique characteristics of the
records of those people found at each facility are presented.
Similarities and differences existed between the two as
unique, but interrelated, organizations and these are of
historical interest of themselves.

As record keeping was

both somewhat more confused (as to exactly who was at each
facility on a given date) and more intact than originally
expected, the opportunity to consider all institutionalized
people in North Dakota on January 1, 1980 was capitalized
upon.
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The age of all individuals averaged 37.09

(SD = 17.11)

years at the time of the 1980 Study Date and had averaged
12.82

(SD = 10.93) years old at the time they were admitted

to the institutional system.
Table 3.

As of the initial Study Date,

Time variable comparisons by setting.

Time Variable

Facility

Admit Age

GSS

864

12.50

10.65

SH

145

14.75

12.34

GSS

866

35.39

16.15

SH

145

47.28

19.15

GSS

864

22.97

13.62

SH

145

32.53

14.48

GSS

866

35.38

16.15

SH

145

47.28

19.15

1980 Age

Years in
Institutions

Facility Comparisons

t

Age at Admission

2.303

1007

Study Age

7.751

1009

Years Institutionalized 1980

7.985

1009

V
a

\—1
o

10.141

793

Placement Age

h->

o

Sig.

V

df

Std. Dev.

O
I—1

Mean Years

A

Placement Age

N

p< .01

average years of institutionalization was 24.35 years
14.14) with the range of .02 years to 66.58 years.

(SD =

Table 3

displays the time-related demographics for each of the

66
facilities, with each facility identified by the name as it
was known in 1980 (i.e., Grafton State School is GSS, San
Haven is SH).

A series of comparisons between the people in

the two facilities is displayed at the bottom of the table.
Although age of life events are an important way to
examine the two populations, level of mental retardation
provides a more direct examination of the characteristics of
the population institutionalized.

This variable reflects the

ability level related to the condition.

These data are

reflected in Tables 4 and 5.
Table 4. Mental retardation level by gender, and setting of
the people with surviving archival records.
Grafton St. School
(N=867 )
Level of MR

Female

San Haven
(N= 145)

Male Female

Total
(N=l,012)

Male Female

Male

3

20

7

67

81

11

10

90

108

105

16

23

118

128

148

150

32

34

180

184

Unspecified MR

2

2

2

2

Missing

7

10

6

6

13

16

408

459

65

80

473

539

Normal

3

20

Mild MR

67

74

Moderate MR

79

98

Severe MR

102

Profound MR

Totals

Facility Percent(47.0) (53.0)

(44.9 )

(55.1)

(46.7) (53.3)

To put these numbers in a larger context, prevalence
estimates of mental retardation in the general population
range from 2% to 3% (APA, 1994), which would equate to
approximately 13,000 to 19,500 people of the approximately
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650,000 citizens of North Dakota.

At the peak, there were

under 1,300 people (0.2%) of the state's population, or
between 6 to 10 percent of the estimated total number of
people with mental retardation, who were institutionalized.
As a distribution across levels of mental retardation at
each facility, the characteristics of the two are compared on
a series of variables to examine differences which might make
a difference when making comparison to the Grafton State
School administrative records on medication use.

These

facility functioning level profiles can be found in Table 5
and medication profiles in Table 6.

The pattern of

functioning was different between the two facilities

(Pearson

Chi-Square = 23.193, df = 5, p.<.01) with San Haven serving
predominately less capable people.
Table 5. Proportion of people at each facility by level of
mental retardation.
Grafton St. School
(N=:867)
Level of MR

Count

Percent

San Haven
(N=-145)
Count

Percent

Total
(N=l,012)
Count

Percent

23

2.3%

23

2.7%

Mild MR

141

16.6%

7

5.3%

148

15.1%

Moderate MR

177

20.8%

21

15.8%

198

20.1%

Severe MR

207

24.4%

39

29.3%

246

25.0%

Profound MR

298

35.1%

66

49.6%

364

37.0%

4

.5%

2

.4%

Normal

Unspecified MR
Totals
Missing of N

17

983

133

850
2.0%

12

8.3%

29

2.9%

Medication use patterns, the central issue, is examined
to consider what differences may be contributed by combining
the two populations.

An examination of the two groups by

psychoactive medications

(psychiatric and seizure combined),

and separate categories of psychiatric and seizure
medications is provided in Table 6.

Given that most of the

Table 6. Proportions of people at each facility by type of
medication, with Pearson Chi-Square comparison on each
setting.
Grafton St. School
(N= 867)

Total
(N=l,012)

San Haven
(N==145)

Count

Percent

Count

Percent

Count

Percent

Psychoactive-Y

454

54.8%

76

59.4%

530

55.4%

Psychoactive-N

375

45.2%

52

40.6%

427

44.6%

Psych. Use-Y

249

30.0%

31

24.2%

280

29.2%

Psych. Use-N

581

70.0%

39

75.8%

678

70.8%

Seizure Med-Y

276

33.3%

48

37.5%

324

33.8%

Seizure Med-N

554

66.7%

80

62.5%

634

66.2%

Medication

SH/GSS Comparisons

Pearson Chi-Square

df

Si g .

Psychoactive Med Use

0.954

1

p= .329

Psychiatric Use

1.792

1

p= .181

Seizure Medication Use

0.894

1

p= .344

people had data available for analysis

(psychoactive

medications = 957, psychiatric use medications = 958, and
seizure medications = 958) the facilities were similar.
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The psychiatric medication use pattern reported by the
administrative recording system in 1980 and 1989 is provided
for comparative purposes to estimate the capacity of this
data collection method to reflect the population's
experiences.

Data collection was initiated by Dr. Kenneth

Yearwood in December, 1980 on the use of medications
(memorandum to the Superintendent from Dr.Yearwood, January
14, 1987) with 30.1% on psychiatrically used medications
compared to the study results of 30% without the known San
Haven people, and 29.2% explicitly including San Haven
residents.

The data was administratively summarized again

from a computer printout completed on January 12, 1989 (after
San Haven closed) using all 281 of the individuals then at
the Developmental Center (AIMS printout,
281, 256 are study participants.

1/12/89).

Of those

Psychiatrically used

medications total 20.3 percent of the 281 residents, and the
archives review of this study produced 20.9% of those from
1980 remaining in the institution at the same time period.
Meanwhile, the Burd Studies

(Burd, Fisher et a l ., 1991;

Burd, Williams et a l ., 1997) provide proportions of similar
variables for people throughout the community in 1988 and
1993.

Their results of 18% in data collected in 1988 is very

similar to this study (19.2%) of psychiatrically used
medications.

On the dimension of overall psychoactive

medication, the community data reflected a stable 37% (1988)
and 38% (1993), and the previously institutionalized group
now in the community displays a 40% (1989) and then 51%
(1995) in overall medication use.
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Psychotropic Medication Use with Standards
Psychotropic medication use in the institution following
the implementation of standards is evaluated through the
McNemar Test in comparing the proportions in 1980 and 1989
for those remaining in the institution.

Another McNemar Test

series is used to evaluate any proportional change from 1989
in the 1995 data (examining stability of any

effect), as

well as a comparison of proportions from 1980 to 1995.

Data

is provided in Table 7 which describes available data used in
each analysis.
Table 7.

Types of data points available for analysis.
Individuals Available for Analysis
1980

1989

1995

1,012

898

793

Psychoactive

957

722

664

Psychiatric Use

958

721

664

Seizure Use

958

722

659

Medication Type
Surviving Individuals

A series of cross-tabulations were computed from the
above available data for use in the McNemar Test to evaluate
differences in psychoactive, psychiatric and seizure use
medications.

The comparative data for 1995 is provided in

the same table for each of the medication conditions as the
data for 1989.

The series of McNemar Tests for the 1980-89

institutional patterns are provided in Table 8 for each
medication condition, with the 1980-95 comparisons provided
in Table 9.

Comparison tables for 1989-95 are in Table 10.
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Table 8. Cross tabulations used to calculate McNemar Test
for those remaining institutionalized.
Psychoactive 1995

Psychoactivei 1989
Psychoactive
1980
No Med
Med

Psychiatric
1980
No Med
Med

Med
13

No Med
49
48

Med

68

9

121

Psychiatric 1989

Psychiatric 1995

No Med
129

No Med
52

Med
17

47

33

23

Seizure Med 1995

Med
15

No Med
104

Med
15

11

38

Seizure Med 1989
Seizure Med
1980
No Med

Med
10

No Med
14

Med
16

No Med
32

42

9
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Table 9. Cross tabulations used to calculate McNemar Test
for 1989 and 1995 medication patterns
Psychoactive 1995
Psychoactive___________
No Med
Med
1989
13
20
No Med
Med

Psychiatric 1995
Psychiatric
1989
No Med
Med

66

3

Seizure Meds 1995
Seizure __________________
1989
No Med
Med
No Med
129
17
Med

47

38

No Med
40
1

Med
9
50
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Table 10. McNemar Test series regarding related pair-wise
comparisons.
McNemar Tests
Psychoactive
1980 & 1989

Psychiatric
1980 & 1989

Seizure
1980 & 1989

231

231

231

Chi-Squarea

18.951

13.141

6.021

Sig.

\—1
o

jo<.01

p>. 01

Psychoactive
1980 & 1995

Psychiatric
1980 & 1995

Seizure
1980 & 1995

101

101

99

p > .01

p>. 01

s—1
o
A
Pi

Psychoactive
1989 & 1995

Psychiatric
1989 & 1995

Seizure
1989 & 1995

102

102

100

N

N

Pi

Sig.

V

N

Chi-Square3
Sig.

0.346
p>.01b

p<.01b

p > .01b

a - Continuity Correction
b - Binomial distribution used
The pattern of differences and obvious decrease in the
use of psychiatric purpose medications is also seen in the
decrease of the combination variable, Psychoactives.

The

decrease in Psychoactive and Psychiatric medications reverses
by 1995, to disappear in contrast to the 1980 levels.
Seizure medication patterns, although displaying a moderate

decrease, does not reach a significant level at any time
point for those living in the institution.
Institution and Community Comparison
Examination of later patterns must be done in the
context of factors occurring in 1980 (Table 11).

Finding a

good way to provide information about previous medication
status is complicated given the various ways of examining the
issue.

Table 11 provides a sense of where everyone went in

the follow up study years as a function of their 1980
medication status.
Table 11.
Proportion of each setting with 1980 medication
group members, as a proportion of the later setting in 1989
and 1995.
1980 Medication Prescribed
Institution

Community

Variable

1980

1989

1995

1989

1995

Psychoactives

55.4

73.5

76.9

49.5

52.8

Psychiatric

29.2

36.8

33.7

26.8

28.7

Seizure Med

33.8

48.7

51.9

29.0

31.6

Neuroleptic

15.1

22.6

23.1

12.7

14.2

In order to understand the impact on the population of
medication use in 1989 and 1995 in the two settings,

it is

important to understand the base rate occurring in 1980.
Table 11 provides a tremendous amount of information in a
concise fashion; however, it must be reviewed carefully to
avoid misinterpretation.

The data from 1980 is the actual

percentages, where the 1989 and 1995 data for institution and
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community is the percentage in each setting at each date of
the people who were receiving those medications in 1980.
The medication use patterns between those who moved to
the community as compared to those remaining in the
institution is compared through the Mann-Whitney U Test with
the data displayed in Table 12.
Table 12. Mann-Whitney U test of independent cells of each
type of medication use for 1989.

Residence

N

Mean
Rank

NDDC

233

407 .21

Community

489

339 .72

NDDC

233

375 .64

Community

488

354..01

NDDC

233

398 .19

Community

489

344..02

NDDC

233

365 .38

Community

489

359 .65

Psychoactives

Psychiatric

Seizure Meds

Neuroleptics

Sum of
Ranks

94880..50
166122..5
87525..00
172756,.0
92778..00
168225,.0
85134..00
175869..0

Mann-Whitney U Test
Psychoactive
Mann-Whitney U
Sig.

46317.5
pc.Ol

Psych.

Seizure

53440.0

48420.0

56064.0

p<.01

p>.01

p>.01

Neuroleptics

The combined variable of Psychoactive medications and
the specific category of Seizure medications demonstrate a
difference between the two settings, with the smaller
proportion in the community settings in each case.
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Community Rates Post-Institutionalization
Evaluation of the third hypothesis requires the
examination of those individuals residing in the community
and an examination of the proportionate changes in medication
use patterns.
Table 13.

The proportions for that cohort is provided in

The hypothesis prediction would be supported if

the percentage of psychiatric use medications increased in
the 1989 or 1995 time periods.
Table 13. History of medication use patterns for residents
now in the community setting.
1980

1989

1995

Psychoactive

57.5%

45.2%

55.0%

Psychiatric

31.1%

19.6%

28.3%

Seizure

35.1%

30.4%

35.3%

Neuroleptics

17.0%

11.0%

10.9%

Medication

Cross tabulations for each medication variable between
Study Dates is provided in Table 14. This allows an
examination of the treatment individuals received through
movement between use and non-use of each medication variable.
For convenience of reading, the 1980 rows continue across the
table to allow the same variable to be examined at both
times.

Because the comparisons between the 1989 and 1995

would require a third dimension to the table which is not
possible on two dimensional paper, these cross tabulations
are provided in Table 15.
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Table 14. Cross tabulations used to calculate McNemar Test
for those moving to the community.

Psychoactive
1980
No Med
Med

Psychiatric
1980
No Med
Med

Seizure Med
No Med
1980

Psvchoactive 1989
Med
No Med
39
243

Psychiatric 1989
Med
No Med
47
410

Seizure Med 1989
Med
No Med
30
401

Med

Neuroleptics
1980
No Med

Neuroleptics 1989
Med
No Med
28
524
45

68

Med

23

Seizure Med 1995
Med
No Med
16
32
42

9

172

61

Psychiatric 1995
Med
No Med
15
52
11

83

123

68

9

261

120

Psvchoactive 1995
Med
No Med
14
10

Neuroleptics 1995
No Med
Med
35
506
36
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Table 15. Cross tabulations used to calculate McNemar Test
for 1989 and 1995 medication patterns for those moving to the
community
Psvchoactive 1995
Psychoactive No Med Med
80
1989
No Med 279
Med

17

280

Seizure Med 1995
Seizure Med No Med Med
40
No Med 413
Med

9

189

Psychiatric 1995
Med
Psychiatric No Med
84
1989
No Med 442
Med

26

103

Neuroleptic 1995
Med
Neuroleptic No Med
20
1989
No Med 562
Med

19

53
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Table 16. McNemar Test series regarding related pair-wise
comparisons for individuals who moved to the community.
McNemar 'rests
Comparison Variable

N

Chi-Squarea Significance

Psychoactive 80/89

663

40 .252

p< .01

Psychoactive 89/95

656

39 .629

p< .01

Psychiatric 80/89

663

33 .088

.01
E>< •

Psychiatric 89/95

655

29 .536

.01
E< ■

Seizure Meds 80/89

664

9 .890

.01
B< ■

Seizure Meds 89/95

651

18 .367

p< .01

Neuroleptics 80/89

665

15 .844

p< .01

Neuroleptics 80/95

653

14 .414

p< .01

a -Continuity Corrected

Table 16 provides the analyses of comparisons for just
those people who moved to the community.

The overall rates

of 1980, again, need to be considered in terms of their
original treatment status, which is accounted for here in the
McNemar Test for related groups.

All other comparisons were

also completed in an examination of these variables, but non
significant findings were not included in the table in order
to increase clarity.

Simply, medication rates decreased from

1980 to 1989 across all medication areas, and increased again
in all areas except Neuroleptics by 1995.

Differences were

only found for Neuroleptics between the 1980 and 1995 dates.
To illustrate the pattern of medication changes across
the years, Table 17 provides an overview of each variable by
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each setting, across each of the years of the study.

The

basic pattern is repeated in each setting, with a decrease in
1989, followed by a return to near previous levels by 1995
with the exception of the neuroleptics.
Table 17. Medication use proportions of each setting at each
time point.
Medication

1980
Inst. Comm

Psychoactive
Total

Psychiatric
Total

Seizure
Total

Neuroleptics
Total

76 .9%

57 ..5%

55 ..4%

33 .7%

31..1%

29 .2%

51..9%

35 .1%

33 .8%

23 .1%

17 .0%

15 ,
.1%

1989

1995

Inst

Comm

Inst

Comm

58..4%

39 .7%

77 ,
.5%

51.,2%

45.,7%

24 .0%

18 .0%

20..0%

40 .8%

25 ,
.8%

30..6%

11,.8%

10 .4%

10,.9%

55 .3%

38 .2% 26 .9%
28 .
,6%

59 .0%

31..1%

35..4%

10 .8%

11 .3%

11..2%

CHAPTER IV
DISCUSSION
From the changes measured in this population's
characteristics over the 15 year time period encompassed in
this study the improvement in service opportunity is
dramatic.

Although it is clear those people remaining in the

institution experienced an overall decrease in medication use
across all categories, the same was true of the general
population of people from the institution.

However, the fact

that proportions of every group returned to near base-line
levels is a rather astonishing finding.

The important

exception to this rebound is the Neuroleptic class of
medications, which dropped by about one-third in their use
(15.1% to 10.1%) and remained there in 1995

(11.2%).

Population Characteristics
Although the age of the individuals at the San Haven
facility averaged over ten years than the people at the
Grafton facility in 1980 (47.28 years vs. 35.38 years),
average years of admission at the time of the initial Study
Date (32.53 vs. 22.97 years), and the same was true of the
average age of placement (57.78 years vs. 41.59 years), the
average age for admission of the individuals was relatively
similar (14.75 years vs. 12.50 years).

This would indicate

that a significant characteristic at the time of
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institutionalization (age) was similar to the overall
population, but the San Haven individuals were an older
subset of the institutionalized population.

There are a

variety of dimensions that can be examined for differences in
the population, however all of these individuals were
institutionalized whether they were served at the same time
in one facility.

In fact, as placements began to make

maintenance of a second facility untenable,

those remaining

in San Haven were transferred to space at the Grafton
facility by the time of closure.
The functioning level, medication use pattern, and the
level of mental retardation at the San Haven facility is
proportionately lower than the Grafton facility (Table 3) in
1980.

The San Haven facility had been described by Assistant

Superintendent Paul Witucki

(personal communication,

1983) as

a location for people with few ties to the Grafton site,
either by not having family concerned about location, or by
family seeking placement at San Haven to be closer for
themselves to visit.

Mr. Witucki worked in various staff

positions at the Grafton State School for over 35 years when
he retired in 1996 and served as Assistant Superintendent for
the last 20 years.
The original intent to avoid what was considered the
lack of records from San Haven.

Instead,

it was found to be

fortuitous that the records which were recoverable enabled
the inclusion of a greater proportion of North Dakota's
institutionalized population.

Institutional Medication Use Pattern
Administrative records at the then Grafton State School,
now North Dakota Developmental Center, provided clear
evidence of a decrease in psychiatric medication use in the
early years of the 1980's.

The data supports the hypothesis

that standards do decrease medication use, however that
decrease did not remain stable except for the Neuroleptics.
Initially, there had been some confusion over whether to
discriminate between those with diagnoses and those without
diagnoses (i.e., for "behavioral" reasons).

Standards and

policies in the late-1980's established the need for
formalized plans if any psychoactive, non-seizure use
medication were prescribed.

This obviated even the need for

diagnoses, although it also permitted a more intellectually
honest approach to diagnostic evaluation.
When distinctions existed between receiving medications
with or without a diagnostic label, significant pressure
existed for the psychologists and physicians.

The teams were

often faced with the need to develop a thoroughly detailed,
formal intervention plan requiring much time and other
resources.

The psychologist was generally responsible for

doing the diagnostic evaluations.

Political pressures were

even brought by staff approaching the consulting psychiatrist
to obtain a diagnosis and thereby professionally
"outflanking" the psychologist.

These diagnostically related

games were eliminated by requiring plans to be in place even
if a diagnosis is provided.
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In most respects then, there was some pressure through
administrative hassle to minimize the use of medications as a
way of avoiding the work involved in developing such plans.
Further, as the agencies were first attempting to meet
standards with which they were unfamiliar there were extreme
interpretations in some situations, and an overall resistance
to enter into anything that was complicated to do -- such as
medication use.

This may help to explain the accompanying

decreases in seizure medications, which should have been less
subject to these effects as their use is based upon periodic
objective testing and physiological reactions.

Seizure

medications, also, were being examined closely during this
time period as the records on many people were poor as to how
well the symptoms were documented.

Monotherapy, or single

drug treatment, was also an important concept being
implemented at that time.

Lastly, there was a time in this

period where literal drug holidays were being recommended
(Rinck, 1998), at which point problems that had been
prompting medication use may have remained dormant or minimal
for some time after discontinuation, but which would not last
forever.
By 1995 the decreases in medication use disappeared,
again with the important exception of the Neuroleptic which
remained decreased.

Whether these politically arranged and

maintained pressures decreased as the system matured, or the
technology and accuracy of medication use increased, or there
new developments in pharmacology made more conditions
treatable through medications, none of these can be

determined as is beyond the scope of this study.

The effects

were supposed to be maintained over time.
Community/Institution Comparisons
Right from the beginning the population of this study
could have been changing.

People continued to be admitted to

the Developmental Center after January 1, 1980 and will do so
into the future.

The characteristics of the institution are

even changing towards that of simply a state-operated
community residential, vocational, and social services
agency.

One characteristic that appears to remain constant

in the North Dakota developmental disabilities system is the
need for a zero-rejection service option.

When the

complexity an individual presents is more than the resources
of the private service agency, or other state or public
school agency, the Center is a place of last recourse.
Over 15 of those institutionalized in 1995 were known to
have been placed into the community and returned to the
Center,

in some cases with several attempts.

Of very

positive note, only two of those people were returned during
the 1989 to 1995 time period.

The remaining individuals at

the Center in the late 1990's, about one-third of the
population current population, had never been admitted to the
Center until this admission.

Efforts to curb admissions to

the Center have not been highly successful, as the 1993
Developmental Center budget projection was designed to serve
an average daily population of 127 which has never been
achieved (current population is approximately 140).

Despite this, and in contrast to successful decreases in
medication use in the institution in the first hypothesis,
the community residing individuals do not require a higher
use of medications in comparison with those "left behind" in
the institution.

To the contrary,

individuals in the

institution are given psychoactive medications at a higher
rate than the community counterparts

(58.4% to 39.7%) but

primarily in the area of medications for seizure management
(40.8% to 25.6%) to a significant degree

(Table 12).

This

was not the case for either Psychiatric Use medications or
the specific subset of Neuroleptics. Both groups sustain
their decrease in Neuroleptics through 1995, but the general
return towards 1980 proportions in medications use is
pervasive across all other categories

(Table 13) despite

setting.
Community Medication Use Patterns
It is not entirely clear if the features of the increase
in Psychoactive medication use was noticeable in general ways
in this investigators clinical practice and therefore
contributed to the errant third hypothesis.

It is now

apparent that people in the community would be receiving as
high a rate of medication use as they were receiving in the
institution, but not until after a significant decrease by
1989 that was a matched characteristic of the entire
population of study.

The increase in medication use simply

returned them, to near the 1980 level that had been
experienced in the institution.

Perhaps that was an

appropriate rate of medication use for the population.

It is striking that the 1989 data was so similar to the
Burd, Fisher et a l . (1991) data collected in North Dakota
group homes in 1988

(Psychoactives = 37% in the Burd Study,

39.7% in this study; Psychiatric Use = 18.0% Burd Study,
18.0% in this study).
1993

Whereas the later study conducted in

(Burd, Williams et a l ., 1997) displayed a minor increase

(e.g., 37% to 38% in Psychoactive medications; 18% to 20% in
Psychiatric Use medications), such minor changes are
negligible -- unless, as a total population measure (97%
return rate) it was indicative of a rise in overall use
(besides just with the deinstitutionalized population).
Between 1989 and 1995 the people that had been
institutionalized, which were now living in the community,
showed a dramatic increase back to the range that had been
characterized as "excessive" by the plaintiffs and recognized
as such by the federal court (ARC v. Olson. 1982) in 1980.
Summary and Conclusions
It remains to be further studied as to the ramifications
of standards, policies, and procedures that are state-of-theart in medication use, and what role this has on changing
medication use rates over time.

As discussed in the

introduction, the movement towards recognizing people with
mental retardation as capable of having mental illness has
been dramatic.

Several scales towards objectivity have been

or continue to be in development, entire organizations have
been founded or subgroups formed, and fewer people than ever
are being segregated in institutions.

The process of collecting information about the course
each life has taken after such a dramatic shift of events as
occurred in North Dakota has been a fascinating one.
Embedded within the immense database that has been developed
as part of this project, there are several more answers to
the question "What happened to the Class

(-action lawsuit) of

ARC vs. Olson", and -- possibly more important -- questions
that will arise from the patterns of life events.

This is

beyond the scope of a dissertation, but promises to be a
fascinating adventure for the next few years.

Through this

project, support has been generated for an annual review of
the status of those individuals remaining.

Thus, the story

is not over!
Questions already being asked about the
deinstitutionalization process have to do with quality of
life, mortality patterns, cost of services, protection of the
individual and society, and similar issues.

As is always the

case with scientific endeavor, the answering of the questions
posed in this study have only prompted further questions to
investigate.
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